<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">B4gxCh547LbYqN3rVQFpcNM</article-id>
      <article-id pub-id-type="other">00012</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2011000300012</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(11)09600312</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2011005000006</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Teste de inclina&#231;&#227;o (Tilt-test): do necess&#225;rio ao imprescind&#237;vel</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Macedo</surname>
            <given-names>Paula Gon&#231;alves</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leite</surname>
            <given-names>Luiz R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santos-Neto</surname>
            <given-names>Leopoldo</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hachul</surname>
            <given-names>Denise</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Faculdade de Medicina de S&#227;o Jos&#233; do Rio Preto</institution>
        <institution content-type="orgdiv1">Centro de Fibrila&#231;&#227;o Atrial do Distrito Federal </institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff03">
        <addr-line>
          <named-content content-type="state">Distrito Federal</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de Bras&#237;lia</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina </institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>03</month>
        <year>2011</year>
      </pub-date>
      <volume>96</volume>
      <issue>3</issue>
      <fpage>246</fpage>
      <lpage>254</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>06</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>01</day>
          <month>12</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>04</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>O teste de inclina&#231;&#227;o (TI) &#233; muito utilizado para a investiga&#231;&#227;o de s&#237;ncopes e pr&#233;-s&#237;ncopes, pois possibilita o diagn&#243;stico de diferentes tipos de disautonomias. A principal causa de s&#237;ncope &#233; a S&#237;ndrome Vasovagal, cujo diagn&#243;stico &#233; o mais frequente entre as indica&#231;&#245;es de TI. O exame &#233; utilizado h&#225; cerca de 20 anos, mas muitos m&#233;dicos desconhecem a metodologia. S&#227;o importantes a indica&#231;&#227;o apropriada, ap&#243;s exclus&#227;o de causas card&#237;acas de s&#237;ncope, e a orienta&#231;&#227;o do paciente para garantir a tranquilidade e a seguran&#231;a do teste. Existem controv&#233;rsias na literatura sobre a capacidade diagn&#243;stica e a confiabilidade dos resultados. Os estudos com protocolos diversos podem explicar a variabilidade dos resultados. Nesta revis&#227;o, s&#227;o colocadas as indica&#231;&#245;es e a metodologia recomendadas pelas diretrizes, complica&#231;&#245;es, limita&#231;&#245;es e perspectivas desse exame.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Teste de inclina&#231;&#227;o</kwd>
        <kwd>s&#237;ncope</kwd>
        <kwd>s&#237;ncope vasovagal</kwd>
        <kwd>protocolos cl&#237;nicos</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>21</day>
        <month>01</month>
        <year>2011</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>Teste de inclina&#231;&#227;o (<italic><bold>Tilt</bold></italic>-test) - do necess&#225;rio ao imprescind&#237;vel</p>
    <p>
      <bold>Paula Gon&#231;alves Macedo<sup>II,III</sup>; Luiz R. Leite<sup>II</sup>; Leopoldo Santos-Neto<sup>III</sup>; Denise Hachul<sup>I</sup></bold>
    </p>
    <p><sup>I</sup>Faculdade de Medicina da Universidade de S&#227;o Paulo, S&#227;o Paulo, SP </p>
    <p><sup>II</sup>Centro de Fibrila&#231;&#227;o Atrial do Distrito Federal - Hospital de Base </p>
    <p><sup>III</sup>Universidade de Bras&#237;lia, DF - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="nt">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p>O teste de inclina&#231;&#227;o (TI) &#233; muito utilizado para a investiga&#231;&#227;o de s&#237;ncopes e pr&#233;-s&#237;ncopes, pois possibilita o diagn&#243;stico de diferentes tipos de disautonomias. A principal causa de s&#237;ncope &#233; a S&#237;ndrome Vasovagal, cujo diagn&#243;stico &#233; o mais frequente entre as indica&#231;&#245;es de TI. O exame &#233; utilizado h&#225; cerca de 20 anos, mas muitos m&#233;dicos desconhecem a metodologia. S&#227;o importantes a indica&#231;&#227;o apropriada, ap&#243;s exclus&#227;o de causas card&#237;acas de s&#237;ncope, e a orienta&#231;&#227;o do paciente para garantir a tranquilidade e a seguran&#231;a do teste. Existem controv&#233;rsias na literatura sobre a capacidade diagn&#243;stica e a confiabilidade dos resultados. Os estudos com protocolos diversos podem explicar a variabilidade dos resultados. Nesta revis&#227;o, s&#227;o colocadas as indica&#231;&#245;es e a metodologia recomendadas pelas diretrizes, complica&#231;&#245;es, limita&#231;&#245;es e perspectivas desse exame.</p>
    <p><bold>Palavras-chave: </bold> Teste de inclina&#231;&#227;o, s&#237;ncope, s&#237;ncope vasovagal, protocolos cl&#237;nicos.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>O teste de inclina&#231;&#227;o (TI) ou<italic> Tilt-test</italic> &#233; um m&#233;todo muito utilizado para a investiga&#231;&#227;o de s&#237;ncope, pr&#233;-s&#237;ncopes, tonturas, palpita&#231;&#245;es relacionadas ao ortostatismo e quadros disauton&#244;micos<sup>1</sup>. No entanto, a principal indica&#231;&#227;o tem sido a investiga&#231;&#227;o da S&#237;ndrome Vasovagal (SVV). </p>
    <p>Em 1986, Kenny e cols.<sup>2</sup> reportaram, pela primeira vez, a utilidade do TI na investiga&#231;&#227;o de pacientes com s&#237;ncope de prov&#225;vel origem vasovagal. Observaram que a exposi&#231;&#227;o &#224; inclina&#231;&#227;o de 60&#176; por 60 minutos desencadeava o reflexo vasovagal em 66% dos pacientes com s&#237;ncope de origem inexplicada. Desde ent&#227;o, v&#234;m sendo testados protocolos de menor dura&#231;&#227;o ou associados a drogas, com o objetivo de aumentar a sensibilidade e abreviar o tempo de execu&#231;&#227;o do teste. </p>
    <p>Recentemente, o exame tem recebido cr&#237;ticas devido &#224;s taxas de sensibilidade e especificidade muito vari&#225;veis nos diferentes estudos. Al&#233;m disso, o resultado do TI n&#227;o tem implica&#231;&#227;o terap&#234;utica bem definida, e a reprodutibilidade &#233; limitada<sup>3,4</sup>.</p>
    <p>A Diretriz Europeia de S&#237;ncope, atualizada em 2009, descreve as recomenda&#231;&#245;es da metodologia e das indica&#231;&#245;es do exame e os tipos de resposta esperados<sup>5</sup>. Neste artigo, discutiremos as atuais indica&#231;&#245;es, protocolos, limita&#231;&#245;es e perspectivas desse exame.</p>
    <p>
      <bold>Indica&#231;&#245;es do teste de inclina&#231;&#227;o</bold>
    </p>
    <p>O Consenso Americano de S&#237;ncope de 2006 n&#227;o recomenda o TI para avalia&#231;&#227;o de s&#237;ncope, por&#233;m esse documento recebeu muitas cr&#237;ticas que ser&#227;o comentadas adiante<sup>6,7</sup>. Na pr&#225;tica cl&#237;nica, utilizam-se as indica&#231;&#245;es preconizadas pela Diretriz Europeia de S&#237;ncope<sup>5</sup>. Essa diretriz estabelece que o TI seja realizado para fins diagn&#243;sticos nas seguintes situa&#231;&#245;es.</p>
    <p>
      <bold>Recomenda&#231;&#227;o Classe I</bold>
    </p>
    <p>Em pacientes jovens, sem doen&#231;a card&#237;aca evidente ou suspeita, com s&#237;ncopes recorrentes de origem inexplicada, nos quais a hist&#243;ria n&#227;o &#233; suficientemente t&#237;pica para o diagn&#243;stico de s&#237;ncope neuromediada.</p>
    <p>Em casos de epis&#243;dio &#250;nico de s&#237;ncope inexplicada, ocorrida em situa&#231;&#227;o de alto risco de trauma f&#237;sico ou com implica&#231;&#245;es ocupacionais; ou em casos de s&#237;ncope recorrente na aus&#234;ncia de cardiopatia, ou ainda, se em paciente portador de cardiopatia, forem exclu&#237;das as causas card&#237;acas de s&#237;ncope.</p>
    <p>Em casos em que a demonstra&#231;&#227;o da susceptibilidade &#224; s&#237;ncope neuromediada tiver relev&#226;ncia cl&#237;nica.</p>
    <p>
      <bold>Recomenda&#231;&#227;o Classe II</bold>
    </p>
    <p>Quando o entendimento do padr&#227;o de resposta hemodin&#226;mica durante a s&#237;ncope puder alterar a programa&#231;&#227;o terap&#234;utica.</p>
    <p>Na diferencia&#231;&#227;o de s&#237;ncope convulsiva e epilepsia.</p>
    <p>No diagn&#243;stico diferencial entre s&#237;ncope reflexa e hipotens&#227;o ortost&#225;tica.</p>
    <p>Para a avalia&#231;&#227;o de pacientes com quedas recorrentes inexplicadas.</p>
    <p>Na abordagem de pacientes com pr&#233;-s&#237;ncope ou tonturas recorrentes.</p>
    <p>Na avalia&#231;&#227;o de pacientes com s&#237;ncopes recorrentes e doen&#231;as psiqui&#225;tricas.</p>
    <p>A diretriz europeia afirma que, nos casos em que o exame &#233; recomendado e na aus&#234;ncia de cardiopatia associada, o resultado positivo com reprodu&#231;&#227;o da s&#237;ncope espont&#226;nea &#233; suficiente para definir o diagn&#243;stico de s&#237;ncope neuromediada.</p>
    <p>A realiza&#231;&#227;o de TI para controle de tratamento ou seguimento da SVV a longo prazo n&#227;o tem sido recomendada. Apesar de a diretriz europeia de s&#237;ncope n&#227;o recomendar a realiza&#231;&#227;o do TI em pacientes com hist&#243;ria cl&#237;nica t&#237;pica de SVV, o teste de inclina&#231;&#227;o tem valor na identifica&#231;&#227;o do tipo de SVV (cardioinibit&#243;ria, vasodepressora ou mista). Alguns autores recomendam diferentes op&#231;&#245;es terap&#234;uticas dependendo do tipo de s&#237;ncope vasovagal, portanto, nesse caso, o TI serviria como orienta&#231;&#227;o terap&#234;utica<sup>5,8</sup>. Pachon e cols.<sup>8</sup> recentemente publicaram uma nova alternativa terap&#234;utica para os pacientes com s&#237;ncope neurocardiog&#234;nica, que seria mais indicado para os pacientes com SVV do tipo cardioinibit&#243;ria.</p>
    <p>
      <bold>Protocolos</bold>
    </p>
    <p>Nas descri&#231;&#245;es dos protocolos j&#225; testados, os termos "sensibilidade" e "positividade" confundem-se devido &#224; inexist&#234;ncia de um teste padr&#227;o-ouro para diagn&#243;stico da SVV. Quando se considera o diagn&#243;stico cl&#237;nico como padr&#227;o-ouro, tem-se utilizado o termo "sensibilidade do TI", j&#225; que o paciente portador da doen&#231;a foi selecionado por meio da hist&#243;ria cl&#237;nica. Quando o exame &#233; realizado em pacientes com s&#237;ncope inexplicada, o termo "positividade" &#233; geralmente aplicado. Contudo, nesta revis&#227;o, foi padronizado o termo "sensibilidade" para ambas as situa&#231;&#245;es, com o objetivo de simplificar a descri&#231;&#227;o dos estudos, mas entende-se que, em muitos casos, o termo representa apenas a positividade do exame. A utiliza&#231;&#227;o do diagn&#243;stico cl&#237;nico como padr&#227;o-ouro &#233; sujeita a cr&#237;ticas devido &#224; subjetividade inerente ao julgamento m&#233;dico, entretanto, at&#233; o momento, nenhum outro m&#233;todo demonstrou maior acur&#225;cia.</p>
    <p>Inicialmente, os autores recomendavam apenas a inclina&#231;&#227;o ortost&#225;tica por tempo prolongado, sem uso de drogas, denominado protocolo passivo prolongado. Na an&#225;lise de cinco estudos que avaliaram o resultado da exposi&#231;&#227;o &#224; ortostase passiva, com dura&#231;&#227;o m&#237;nima de 40 minutos, os &#237;ndices de sensibilidade observados foram 13%, 25%, 31%, 35% e 75% (mediana de 31%)<sup>9-12</sup>. Em contrapartida &#224; baixa sensibilidade, a especificidade foi de 100%, 100%, 95%, 92% e 89%, respectivamente (m&#233;dia de 95%).</p>
    <p>Na tentativa de aumentar a acur&#225;cia diagn&#243;stica do TI, foi testada a administra&#231;&#227;o de diversas drogas sensibilizantes ap&#243;s a fase passiva, quando o resultado dessa era negativo. </p>
    <p>Atualmente, o isoproterenol e o nitrato s&#227;o as drogas mais utilizadas para esse fim. Nos diversos estudos realizados, a sensibilidade do teste com nitrato variou entre 57,5% e 87%, e a especificidade, entre 70% e 100%, enquanto o teste com isoproterenol apresentou varia&#231;&#245;es entre 42% e 69% e entre 70 e 90%, respectivamente<sup>9,11,13-15</sup>. O isoproterenol vem sendo abandonado devido &#224; menor sensibilidade, aos inconvenientes do acesso endovenoso e dos efeitos colaterais, principalmente em pacientes com cardiopatia isqu&#234;mica<sup>16</sup> (<xref ref-type="table" rid="tab01">Tabela1</xref>).</p>
    <table-wrap id="tab01">
      <graphic xlink:href="1678-4170-abc-96-03-0246-00006-gt01.jpg"/></table-wrap>
    <p>Inicialmente, o nitrato foi utilizado sob a forma de nitroglicerina endovenosa, com sensibilidade de 53% e especificidade de 92%, considerando-se apenas a fase sensibilizada<sup>17</sup>. Em estudo posterior, os mesmos pesquisadores avaliaram o efeito da nitroglicerina sublingual<sup>10</sup>. Inicialmente, os pacientes eram submetidos &#224; inclina&#231;&#227;o de 60&#176; por 45 minutos (inclina&#231;&#227;o passiva), o que resultava em baixa sensibilidade (25%) e elevada especificidade (100%). Ap&#243;s administra&#231;&#227;o de 300 mg de nitroglicerina sublingual, era observada resposta positiva em mais 26% dos pacientes e em 6% do grupo controle, resultando em uma especificidade de 94%. Dados semelhantes foram apresentados por outros autores nos anos seguintes<sup>9,15,18</sup> (<xref ref-type="table" rid="tab01">Tabela 1</xref>). </p>
    <p>A diretriz europeia de s&#237;ncope, publicada em 2004, relata uma an&#225;lise de estudos que utilizaram 20 ou 45 minutos de fase passiva seguida por sensibiliza&#231;&#227;o com nitrato e conclui que a sensibilidade dos exames com menor ou maior dura&#231;&#227;o &#233; semelhante (69% <italic>versus</italic> 62%) sem diminui&#231;&#227;o da especificidade (94% para os protocolos com 20 minutos de fase passiva)<sup>1</sup>. Desde ent&#227;o, recomenda-se que o TI seja constitu&#237;do por 20 minutos de fase passiva e 20 minutos de fase sensibilizada (nitroglicerina ou isoproterenol). Desse modo, o protocolo cl&#225;ssico (sem uso de drogas sensibilizantes) vem sendo substitu&#237;do pelo protocolo que combina a fase passiva seguida por fase sensibilizada.</p>
    <p>No Brasil, a nitroglicerina sublingual n&#227;o &#233; comercializada desde 2002, assim, o vasodilatador utilizado &#233; o dinitrato de isossorbida, na dose de 1,25 mg (1/4 do comprimido de uso sublingual), conforme recomenda&#231;&#227;o das Diretrizes para Avalia&#231;&#227;o e Tratamento de Pacientes com Arritmias Card&#237;acas, publicada em 2002<sup>19</sup>. Em tr&#234;s estudos que avaliaram o uso desse medicamento durante o TI, a sensibilidade oscilou de 57 a 87%, e a especificidade, de 70 a 100%<sup>9,14,15</sup>. A dose de 1,25 mg foi avaliada em apenas um desses estudos e foi aquela associada &#224; maior especificidade (100%)<sup>15</sup>.</p>
    <p>A sensibiliza&#231;&#227;o do exame com uso de nitrato reproduz os mesmos tipos de resposta vasovagal da inclina&#231;&#227;o passiva: cardioinibit&#243;ria, vasodepressora e mista<sup>20</sup>. Entretanto, o mecanismo pelo qual o nitrato induz s&#237;ncope vasovagal n&#227;o est&#225; ainda esclarecido, e as hip&#243;teses mais estudadas t&#234;m sido: 1) vasodilata&#231;&#227;o; 2) ativa&#231;&#227;o do sistema nervoso simp&#225;tico; 3) a&#231;&#227;o direta no sistema nervoso central (SNC); e 4) a&#231;&#227;o no sistema nervoso central (SNC) via neuro-horm&#244;nios<sup>20-22</sup>. </p>
    <p>
      <bold>Metodologia recomendada</bold>
    </p>
    <p>O TI deve ser realizado em ambiente tranquilo, com pouca ilumina&#231;&#227;o e temperatura agrad&#225;vel. O acompanhamento &#233; feito por m&#233;dico e auxiliar de enfermagem, treinados para a realiza&#231;&#227;o do exame, e n&#227;o se recomenda perman&#234;ncia de familiares. A sala deve ser equipada com material de reanima&#231;&#227;o cardiovascular, embora a utiliza&#231;&#227;o seja raramente necess&#225;ria<sup>19</sup>. O paciente deve estar em jejum m&#237;nimo de quatro horas para l&#237;quidos e seis horas para s&#243;lidos e deve permanecer deitado previamente &#224; inclina&#231;&#227;o por, pelo menos, dez minutos<sup>19</sup>. Deve-se evitar pun&#231;&#227;o venosa nessa fase, mas se for necess&#225;ria, o tempo de repouso pr&#233;-exame deve ser aumentado para ao menos 20 minutos<sup>1</sup>. A mesa do exame disp&#245;e de suporte para os p&#233;s e cintos de seguran&#231;a e &#233; inclin&#225;vel at&#233; 60 ou 70 graus (<xref ref-type="fig" rid="fig01">Figura 1</xref>). Angula&#231;&#245;es acima e abaixo daquela padronizada apresentam, respectivamente, menor sensibilidade e menor especificidade do TI<sup>1,23</sup>. Durante todo o exame, o paciente &#233; monitorizado pelo eletrocardiograma e medidas da press&#227;o arterial (PA). O ideal &#233; a monitoriza&#231;&#227;o cont&#237;nua e n&#227;o invasiva da PA. Se a PA for avaliada intermitentemente, o intervalo entre as medi&#231;&#245;es deve ser o menor poss&#237;vel, especialmente na fase pr&#243;xima &#224; positiva&#231;&#227;o do exame. Em pacientes com idade acima de 40 anos e hist&#243;ria cl&#237;nica de s&#237;ncope, &#233; recomendada tamb&#233;m a massagem dos seios carot&#237;deos, pois, durante a ortostase, a sensibilidade dessa t&#233;cnica &#233; maior, sendo poss&#237;vel ainda avaliar o componente vasodepressor<sup>24</sup>. O exame pode ser realizado em qualquer per&#237;odo do dia, mas, quando o objetivo for estudar a reprodutibilidade dos resultados, &#233; importante repetir o exame no mesmo hor&#225;rio em que foi realizado previamente<sup>25</sup>. </p>
    <fig id="fig01">
      <graphic xlink:href="1678-4170-abc-96-03-0246-00006-gf01.jpg"/></fig>
    <p>
      <bold>Tipos de resposta ao teste de inclina&#231;&#227;o</bold>
    </p>
    <p>As Diretrizes para Avalia&#231;&#227;o e Tratamento de Pacientes com Arritmias Card&#237;acas considera o crit&#233;rio de positividade do TI quando ocorre reprodu&#231;&#227;o dos sintomas espont&#226;neos associada ao colapso hemodin&#226;mico<sup>19</sup>. Existe controv&#233;rsia quanto &#224; interrup&#231;&#227;o do exame antes de o paciente apresentar a s&#237;ncope. Muitos autores consideram que &#233; suficiente interromper o TI quando o m&#233;dico considera que a perda de consci&#234;ncia &#233; iminente - fase denominada pr&#233;-s&#237;ncope - e que n&#227;o se justifica submeter o paciente a tamanho desconforto em face da hipotens&#227;o ou bradicardia, que possibilitem a defini&#231;&#227;o da resposta vasovagal<sup>1,26,27</sup>. Os estudos mais recentes consideraram o crit&#233;rio de positividade a indu&#231;&#227;o de s&#237;ncope ou de pr&#233;-s&#237;ncope, quando associada &#224; bradicardia ou hipotens&#227;o arterial<sup>11,13,14,18,26,28</sup>. </p>
    <p>A classifica&#231;&#227;o modificada do VASIS (<italic>Vasovagal Syncope International Study)</italic> &#233; a mais aceita para definir os tipos de resposta ao teste de inclina&#231;&#227;o: tipo 1 ou mista; tipo 2A ou cardioinibit&#243;ria sem assistolia; tipo 2B ou cardioinibit&#243;ria com assistolia; e tipo 3 ou vasopressora (<xref ref-type="table" rid="tab02">Tabelas 2</xref> e <xref ref-type="fig" rid="fig02">Figura 2</xref>)<sup>1</sup>. </p>
    <table-wrap id="tab02">
      <graphic xlink:href="1678-4170-abc-96-03-0246-00006-gt02.jpg"/></table-wrap>
    <fig id="fig02">
      <graphic xlink:href="1678-4170-abc-96-03-0246-00006-gf02.jpg"/></fig>
    <p>O tipo de resposta ao TI, entretanto, n&#227;o necessariamente define o padr&#227;o hemodin&#226;mico da s&#237;ncope cl&#237;nica do paciente. O estudo ISSUE-2 mostrou que 36% dos pacientes com resposta mista ou vasodepressora ao TI, apresentavam assistolia durante o epis&#243;dio espont&#226;neo gravado pelo <italic>loop recorder</italic><sup>29</sup>. Assim, mais recentemente, considera-se que a import&#226;ncia da resposta ao teste de inclina&#231;&#227;o &#233; especialmente a diferencia&#231;&#227;o entre s&#237;ncope reflexa e outras formas de intoler&#226;ncia ortost&#225;tica<sup>5</sup>. </p>
    <p>
      <bold>Outros diagn&#243;sticos obtidos por meio do teste de inclina&#231;&#227;o</bold>
    </p>
    <p>Al&#233;m da resposta vasovagal, o TI possibilita o diagn&#243;stico de outras formas de disautonomia e intoler&#226;ncia ortost&#225;tica. A hipersensibilidade dos seios carot&#237;deos &#233; confirmada se, durante a massagem, ocorrer pausa ventricular maior ou igual a tr&#234;s segundos ou queda da press&#227;o arterial sist&#243;lica maior ou igual a 50 mmHg<sup>1</sup>. A realiza&#231;&#227;o da massagem sob inclina&#231;&#227;o possibilita o diagn&#243;stico de metade dos pacientes com a doen&#231;a que n&#227;o seriam diagnosticados se o procedimento fosse realizado apenas em posi&#231;&#227;o supina. Em um estudo retrospectivo com 1.719 pacientes, o diagn&#243;stico de s&#237;ndrome de hipersensibilidade dos seios carot&#237;deos foi feito em 226 casos durante a manobra em posi&#231;&#227;o supina e em 217 casos somente ap&#243;s a repeti&#231;&#227;o da manobra sob inclina&#231;&#227;o<sup>24</sup>. Al&#233;m disso, a monitoriza&#231;&#227;o cont&#237;nua da PA durante o TI facilita a avalia&#231;&#227;o do componente vasodepressor, o que &#233; importante para o diagn&#243;stico, j&#225; que, na maioria dos casos, a s&#237;ncope decorre tanto da queda da FC quanto da queda da PA - resposta mista. </p>
    <p>Outra disautonomia frequente &#233; a S&#237;ndrome de Taquicardia Postural Ortost&#225;tica ou S&#237;ndrome Postural Ortost&#225;tica Taquicardizante, em que o paciente queixa-se principalmente de palpita&#231;&#245;es, tonturas e pr&#233;-s&#237;ncope relacionadas ao ortostatismo. O TI &#233; essencial para a confirma&#231;&#227;o do diagn&#243;stico, que &#233; considerado positivo quando ocorre aumento da FC maior ou igual a 30 bpm ap&#243;s a exposi&#231;&#227;o ortost&#225;tica em rela&#231;&#227;o &#224; FC basal ou manuten&#231;&#227;o de FC superior a 120 bpm durante a inclina&#231;&#227;o<sup>30</sup>. No outro extremo, est&#225; a incompet&#234;ncia cronotr&#243;pica, caracterizada pela falha no incremento da frequ&#234;ncia card&#237;aca durante a inclina&#231;&#227;o, ou seja, incremento menor que 10% da frequ&#234;ncia card&#237;aca basal<sup>31</sup>. Esse diagn&#243;stico s&#243; pode ser feito na aus&#234;ncia do efeito de drogas cronotr&#243;picas negativas.</p>
    <p>O TI possibilita tamb&#233;m o diagn&#243;stico de outras formas de intoler&#226;ncia ortost&#225;tica, como, por exemplo, a resposta disauton&#244;mica, caracterizada por queda lenta e progressiva da PA para n&#237;veis inferiores a 80 mmHg, sem queda da FC, associada a sintomas de hipotens&#227;o arterial como sudorese, tonturas e escurecimento visual<sup>31</sup>. O paciente apresenta esse quadro ao longo de, pelo menos, cinco minutos, sem ocorr&#234;ncia de s&#237;ncope, e, nesse momento, o exame deve ser interrompido.</p>
    <p>As doen&#231;as prim&#225;rias do sistema nervoso aut&#244;nomo (Fal&#234;ncia Auton&#244;mica Pura, S&#237;ndrome de Shy-Drager e a Atrofia Multissist&#234;mica) ou insufici&#234;ncias auton&#244;micas secund&#225;rias a doen&#231;as sist&#234;micas (S&#237;ndrome de Parkinson, diabete melito e Amiloidose) tamb&#233;m podem ser avaliadas pelo TI<sup>32</sup>. S&#227;o caracterizadas por hipertens&#227;o supina e hipotens&#227;o ortost&#225;tica, que n&#227;o se recuperam ap&#243;s os primeiros minutos de exposi&#231;&#227;o postural. Dependendo da intensidade de acometimento auton&#244;mico, esta hipotens&#227;o postural pode ser de maior ou menor magnitude e pode estar acompanhada de aumento insuficiente da FC ou n&#227;o, caracterizando graus mais ou menos avan&#231;ados de insufici&#234;ncia auton&#244;mica. </p>
    <p>
      <bold>Complica&#231;&#245;es</bold>
    </p>
    <p>O TI &#233; um exame seguro se realizado nas condi&#231;&#245;es recomendadas acima e ap&#243;s exclus&#227;o de causas card&#237;acas para s&#237;ncope. Nesse sentido, antes da solicita&#231;&#227;o desse exame, deve ser realizada uma hist&#243;ria cl&#237;nica minuciosa acerca do epis&#243;dio sincopal. Em face da suspeita de causa card&#237;aca ou neurol&#243;gica, deve-se proceder &#224; investiga&#231;&#227;o espec&#237;fica<sup>33</sup>. Leman e cols.<sup>16</sup> reportaram a ocorr&#234;ncia de fibrila&#231;&#227;o ventricular durante um TI com uso de isoproterenol na dose de 5 &#181;g/kg/min em uma paciente de 80 anos, com hist&#243;ria de infarto do mioc&#225;rdio antigo e que estava em investiga&#231;&#227;o de s&#237;ncope, mas n&#227;o havia realizado ecocardiograma ou teste de isquemia mioc&#225;rdica previamente ao TI. Ap&#243;s desfibrila&#231;&#227;o com sucesso, a paciente foi submetida &#224; coronariografia que revelou obstru&#231;&#227;o de 99% na art&#233;ria circunflexa.</p>
    <p>Em contrapartida, um estudo ingl&#234;s atestou a seguran&#231;a desse teste. Foram inclu&#237;dos 1.969 idosos acima de 60 anos, sendo 44% acima de 75 anos, submetidos ao TI pelo protocolo passivo ou sensibilizado pelo gliceril trinitato<sup>34</sup>. Apenas uma paciente de 74 anos apresentou fibrila&#231;&#227;o atrial aos 26 minutos da inclina&#231;&#227;o passiva, &#250;nico evento cardiovascular observado durante os exames, e n&#227;o houve eventos neurol&#243;gicos. Outro estudo realizado na Espanha n&#227;o demonstrou qualquer complica&#231;&#227;o durante o exame de 1.219 indiv&#237;duos, desde jovens a idosos, em que se utilizou a metodologia com apenas a fase passiva ou associada &#224; sensibiliza&#231;&#227;o com isoproterenol<sup>35</sup>. </p>
    <p>N&#227;o &#233; infrequente a ocorr&#234;ncia de assistolia prolongada como resultado do reflexo vasovagal induzido pelo TI, por&#233;m, na maioria dos casos, n&#227;o &#233; necess&#225;rio iniciar manobras de ressuscita&#231;&#227;o, sendo o retorno r&#225;pido &#224; posi&#231;&#227;o supina ou &#224; posi&#231;&#227;o de Trendelemburg suficientes para a recupera&#231;&#227;o hemodin&#226;mica e da consci&#234;ncia. J&#225; foi relatada assistolia de 73 segundos, revertida com manobras de ressuscita&#231;&#227;o e atropina, sem qualquer sequela ap&#243;s o exame<sup>36</sup>. Usualmente, as pausas s&#227;o inferiores a 30 segundos, mas pausas maiores n&#227;o s&#227;o consideradas complica&#231;&#245;es, mas respostas exacerbadas<sup>1</sup>. </p>
    <p>
      <bold>Uso cl&#237;nico e limita&#231;&#245;es</bold>
    </p>
    <p>Pela capacidade de reproduzir os sintomas do paciente em laborat&#243;rio, associado &#224; comprova&#231;&#227;o das altera&#231;&#245;es hemodin&#226;micas, o TI &#233; utilizado para confirmar o diagn&#243;stico da SVV h&#225; mais de 20 anos. Diretrizes espec&#237;ficas recomendam a utiliza&#231;&#227;o para investiga&#231;&#227;o diagn&#243;stica de s&#237;ncopes de origem inexplicada, pr&#233;-s&#237;ncopes, tonturas, quedas e crises convulsivas.</p>
    <p>Em 2006, a Sociedade Americana de Cardiologia apresentou uma Diretriz que sugeria que o TI apresentava pouca contribui&#231;&#227;o na investiga&#231;&#227;o diagn&#243;stica<sup>6</sup>. As cr&#237;ticas reca&#237;am sobre a sensibilidade, especificidade, acur&#225;cia e reprodutibilidade, e apenas quatro refer&#234;ncias foram apresentadas para justificar a desqualifica&#231;&#227;o do teste - enquanto a Diretriz Europeia de s&#237;ncope n&#227;o fora citada. Por outro lado, o <italic>Ad Hoc Syncope Consortium</italic> argumentou que tal documento foi incompleto, apresentou apenas uma vis&#227;o parcial do contexto da doen&#231;a e pecou em n&#227;o endere&#231;ar evid&#234;ncias importantes e atualizadas, tais como a n&#227;o cita&#231;&#227;o da Diretriz Europeia de s&#237;ncope<sup>7</sup>. </p>
    <p>Outros autores tamb&#233;m questionam a validade do TI<sup>3,4</sup>. Em rela&#231;&#227;o &#224; sensibilidade e especificidade, alguns consideram que os resultados s&#227;o muito diversos, a depender do m&#233;todo utilizado, em especial o grau de inclina&#231;&#227;o, da dura&#231;&#227;o da fase passiva, do uso ou n&#227;o de drogas sensibilizantes e do tipo de popula&#231;&#227;o estudada. A varia&#231;&#227;o de resultados &#233; justificada exatamente pela avalia&#231;&#227;o de estudos com metodologias muito distintas, uma das raz&#245;es que levou &#224; padroniza&#231;&#227;o do exame na Diretriz Europeia. Petkar e Fitzpatrick<sup>3 </sup>criticam a baixa sensibilidade do teste apenas com fase passiva e a queda da especificidade quando se utilizam drogas sensibilizantes. Os autores exemplificam a baixa especificidade ao descrever um estudo que encontrou 55% de falsos positivos no teste sensibilizado com isoproterenol<sup>3,37</sup>. No entanto, nesse estudo, o TI foi realizado com inclina&#231;&#227;o de 80&#186;, o que sabidamente reduz a especificidade, n&#227;o sendo recomendado<sup>1</sup>. Da mesma forma, analisando-se estudos mais recentes, observa-se queda importante da especificidade quando, nos protocolos sensibilizados, a fase passiva tem dura&#231;&#227;o maior ou igual a 30 minutos. Protocolos com fases passivas mais curtas, ou mesmo ausentes, seguidos pela sensibiliza&#231;&#227;o com nitrato ou isoproterenol, associam-se a especificidades de 84 a 97%<sup>18,28,38</sup>, enquanto, nos estudos que utilizaram fases passivas mais prolongadas, observou-se redu&#231;&#227;o nas especificidades (48 a 70%)<sup>9,11,15</sup>. Assim, a limita&#231;&#227;o da dura&#231;&#227;o total do exame parece garantir boa especificidade.</p>
    <p>A sensibilidade apenas da fase passiva &#233; bastante vari&#225;vel, mas a maioria dos estudos encontrou baixo &#237;ndice de positividade. Quando essa fase tem dura&#231;&#227;o de 40 a 45 minutos, as sensibilidades encontradas foram de 13%, 25%, 31% e 35%<sup>9-11,26</sup>. Apenas quando a dura&#231;&#227;o foi de 60 minutos &#233; que a positividade aumentou para 75% com queda da especificidade para 89%.<sup>[12]</sup> J&#225; nos testes sensibilizados com nitrato, por exemplo, a sensibilidade varia de 53 a 87%<sup>9,11,13-15,17,26</sup>.</p>
    <p>Considerando-se que a associa&#231;&#227;o de drogas aumenta significativamente a sensibilidade do TI e que a queda da especificidade pode ser aceit&#225;vel, o protocolo combinado &#233; o mais apropriado para uso cl&#237;nico na investiga&#231;&#227;o diagn&#243;stica da s&#237;ncope.</p>
    <p>
      <bold>Teste de inclina&#231;&#227;o na avalia&#231;&#227;o progn&#243;stica</bold>
    </p>
    <p>Alguns estudos j&#225; foram realizados com o objetivo de avaliar a capacidade do resultado do TI de predizer a evolu&#231;&#227;o cl&#237;nica<sup>4</sup>. Hachul e cols.<sup>39</sup> relataram que, ap&#243;s institui&#231;&#227;o do tratamento para S&#237;ndrome Vasovagal, o TI com resultado negativo associava-se a menor recorr&#234;ncia de sintomas em rela&#231;&#227;o ao resultado positivo (4,9 <italic>versus</italic> 52,4%, em 12 meses, p&lt;0,0001). Bastos e cols.<sup>40</sup> analisaram a capacidade do teste em predizer a recorr&#234;ncia dos sintomas ap&#243;s suspens&#227;o da medica&#231;&#227;o e observaram que 84% dos pacientes com TI positivo nessa situa&#231;&#227;o apresentavam recorr&#234;ncia dos sintomas com 12 meses de seguimento. Al&#233;m disso, o tempo m&#233;dio para a primeira recidiva fora significativamente menor nos pacientes com teste positivo em rela&#231;&#227;o &#224;queles com teste negativo. Por outro lado, alguns autores encontraram resultados distintos. Grim e cols.<sup>41</sup> acompanharam 80 pacientes que realizaram TI, com ao menos um epis&#243;dio de s&#237;ncope pr&#233;via, dos quais apenas 14 pacientes tiveram resultado positivo. Ap&#243;s seguimento m&#233;dio de 23 meses, os autores conclu&#237;ram que o resultado do TI n&#227;o fora &#250;til na predi&#231;&#227;o da evolu&#231;&#227;o cl&#237;nica dos pacientes, mas a presen&#231;a de dois ou mais epis&#243;dios pr&#233;vios de s&#237;ncope. Sheldon e cols.<sup>42</sup> demonstraram que o risco de s&#237;ncope em dois anos era semelhante entre pacientes com TI positivo e negativo. O m&#233;todo do teste utilizado foi fase &#250;nica sensibilizada com isoproterenol, sob inclina&#231;&#227;o a 80&#186; e com dura&#231;&#227;o m&#225;xima de dez minutos, ou seja, bastante diverso ao que se utiliza nos dias de hoje.</p>
    <p>O estudo ISSUE tamb&#233;m &#233; utilizado por alguns autores para justificar o baixo valor progn&#243;stico do TI<sup>3,4,43</sup>. Foram inclu&#237;dos 111 pacientes, dos quais apenas 29 (26%) tiveram TI positivo. Em todos os pacientes, foi implantado um monitor de eventos eletrocardiogr&#225;ficos (<italic>loop recorder</italic>), e foi observado que n&#227;o havia rela&#231;&#227;o entre a positividade do TI e bradicardias documentadas no monitor de eventos. No entanto, o diagn&#243;stico etiol&#243;gico da s&#237;ncope foi poss&#237;vel em apenas 20 (18%) dos pacientes (16 por assistolia maior que tr&#234;s segundos, tr&#234;s por bradicardia severa e um por taquicardia parox&#237;stica supraventricular), apesar da utiliza&#231;&#227;o de um dispositivo implant&#225;vel com seguimento de at&#233; 15 meses. O pequeno n&#250;mero de pacientes com resultado positivo em cada um dos testes limita uma conclus&#227;o mais fidedigna dos dados. </p>
    <p>Em estudo recente, foram acompanhados 276 pacientes com diagn&#243;stico cl&#237;nico de SVV por dois anos. O TI, realizado conforme preconizado pela Diretriz Europeia, foi positivo em 37% dos pacientes. Os fatores preditivos positivos de recorr&#234;ncia da s&#237;ncope foram n&#250;mero de eventos sincopais pr&#233;vios, sexo feminino e asma br&#244;nquica, exceto o TI<sup>44</sup>. Portanto, at&#233; que surjam novos estudos, o resultado do TI n&#227;o parece ser &#250;til na avalia&#231;&#227;o progn&#243;stica da s&#237;ncope.</p>
    <p>
      <bold>Teste de inclina&#231;&#227;o na avalia&#231;&#227;o da resposta terap&#234;utica</bold>
    </p>
    <p>Em rela&#231;&#227;o &#224; repeti&#231;&#227;o do TI para avaliar a resposta terap&#234;utica, duas vari&#225;veis devem ser discutidas. Uma poss&#237;vel limita&#231;&#227;o dessa an&#225;lise &#233; a baixa reprodutibilidade do TI quando o primeiro resultado &#233; positivo, que varia de 31 a 92%<sup>1</sup>. J&#225; a reprodutibilidade do teste negativo &#233; melhor - 85 a 94%<sup>1</sup>. Outra vari&#225;vel &#233; a pr&#243;pria indefini&#231;&#227;o de qual medica&#231;&#227;o &#233; realmente efetiva no tratamento da doen&#231;a. J&#225; se tentou justificar como uma poss&#237;vel causa de insucesso da terapia com metoprolol, a sele&#231;&#227;o dos pacientes com resultado positivo no TI sensibilizado com isoproterenol<sup>4,45</sup>. No entanto, um estudo randomizado e controlado com atenolol tamb&#233;m n&#227;o demonstrou redu&#231;&#227;o dos sintomas, apesar de os pacientes terem sido selecionados a partir da caracteriza&#231;&#227;o cl&#237;nica da s&#237;ndrome vasovagal, independentemente do resultado do TI<sup>46</sup>. O insucesso da terapia com implante de marcapasso card&#237;aco tamb&#233;m tem sido atribu&#237;do &#224; sele&#231;&#227;o de pacientes com bradicardia importante ao TI<sup>3,4</sup>, contudo, outros estudos s&#227;o necess&#225;rios para definir a efic&#225;cia da estimula&#231;&#227;o artificial e assim justificar os resultados negativos dos estudos pr&#233;vios por um vi&#233;s de sele&#231;&#227;o.</p>
    <p>
      <bold>Quando o teste de inclina&#231;&#227;o &#233; mais importante?</bold>
    </p>
    <p>Apesar de os pacientes com s&#237;ncope e aus&#234;ncia de cardiopatia terem um &#243;timo progn&#243;stico, muitos deles s&#227;o atormentados pela aus&#234;ncia de diagn&#243;stico definitivo, e a ansiedade subsequente pode resultar em epis&#243;dios mais frequentes de s&#237;ncope vasovagal. Outro bom exemplo da import&#226;ncia do TI &#233; na investiga&#231;&#227;o de pacientes com hist&#243;ria de s&#237;ncope s&#250;bita e com avalia&#231;&#227;o cardiol&#243;gica negativa. O TI pode reproduzir a s&#237;ncope sem pr&#243;dromos, que ocorre porque o paciente n&#227;o percebe a queda da press&#227;o arterial ou da frequ&#234;ncia card&#237;aca, ou porque o colapso hemodin&#226;mico desenvolve-se de forma muito r&#225;pida.</p>
    <p>A SVV &#233; respons&#225;vel por 31 a 34% dos casos de s&#237;ncope em idosos<sup>47,48</sup>. Nessa popula&#231;&#227;o, &#233; especialmente importante a realiza&#231;&#227;o do TI ap&#243;s exclus&#227;o de causa card&#237;aca, pois o diagn&#243;stico correto e a institui&#231;&#227;o do tratamento adequado podem prevenir as quedas e as complica&#231;&#245;es decorrentes da s&#237;ncope, como fraturas e hematoma subdural. Al&#233;m disso, o TI aumenta a chance de se identificar hipersensibilidade dos seios carot&#237;deos, que est&#225; relacionada a at&#233; 20% das s&#237;ncopes nos idosos<sup>49</sup>. O exame &#233; tamb&#233;m muito &#250;til na diferencia&#231;&#227;o com quadros epil&#233;pticos, e a identifica&#231;&#227;o da s&#237;ndrome disauton&#244;mica nesses pacientes evita as limita&#231;&#245;es sociais impostas pelo diagn&#243;stico de epilepsia e os efeitos colaterais decorrentes da medica&#231;&#227;o anticonvulsivante<sup>50</sup>.</p>
    <p>Ainda, &#233; poss&#237;vel caracterizar a s&#237;ncope psicog&#234;nica durante o TI, quando o paciente simula o epis&#243;dio sincopal sem que se observe qualquer altera&#231;&#227;o hemodin&#226;mica associada<sup>51</sup>. Outros diagn&#243;sticos associados &#224; s&#237;ncope, como a intoler&#226;ncia ortost&#225;tica e a S&#237;ndrome de Taquicardia Ortost&#225;tica Postural, tamb&#233;m podem ser revelados ou confirmados pelo TI.</p>
    <p>
      <bold>Perspectivas</bold>
    </p>
    <p>Na tentativa de melhorar a especificidade do exame e a toler&#226;ncia dos pacientes, t&#234;m sido testados protocolos mais curtos do TI. Nesse sentido, os m&#233;todos em estudo t&#234;m avaliado a redu&#231;&#227;o do tempo ou a exclus&#227;o da fase passiva, e os resultados at&#233; o momento s&#227;o conflitantes. </p>
    <p>Em pacientes com s&#237;ncope inexplicada, Bartoletti e cols.<sup>38</sup> compararam os resultados da inclina&#231;&#227;o passiva por 45 minutos <italic>versus</italic> inclina&#231;&#227;o com nitrato precedida por fase passiva de apenas cinco minutos. Nesse estudo, a taxa de positividade foi significativamente superior com o m&#233;todo cl&#225;ssico, de 45 minutos (51% <italic>versus</italic> 35%, p=0,04), sugerindo que fosse necess&#225;ria fase passiva maior antes da administra&#231;&#227;o do nitrato. Entretanto, essa conclus&#227;o diverge de outros estudos. Aerts e cols.<sup>52</sup> avaliaram o tratamento com nitrato precedido por tr&#234;s protocolos de inclina&#231;&#227;o passiva: 45 minutos, 30 minutos e sem fase passiva. Os autores encontraram sensibilidade de 87%, 77% e 76%, respectivamente, e especificidade quase inalterada de 83%, 83% e 82%, respectivamente. Houve pequena diferen&#231;a na acur&#225;cia, embora sem signific&#226;ncia estat&#237;stica, de 78%, 80% e 71%, respectivamente. Al&#233;m disso, nesse estudo, foi encontrada sensibilidade maior do que no estudo de Bartoletti e cols.<sup>38</sup>, consequ&#234;ncia prov&#225;vel da sele&#231;&#227;o de pacientes com hist&#243;ria cl&#237;nica t&#237;pica de s&#237;ncope vasovagal. </p>
    <p>Mais recentemente, Aerts e Dendale<sup>28</sup> analisaram a acur&#225;cia do TI sem fase passiva. Trinta e oito pacientes e trinta indiv&#237;duos saud&#225;veis foram submetidos ao TI ap&#243;s administra&#231;&#227;o de 400 ug de nitroglicerina sublingual, por um per&#237;odo m&#225;ximo de 30 minutos. Observaram-se sensibilidade de 82%, especificidade de 84% e acur&#225;cia de 83%. Os autores relatam ainda que, analisando os resultados obtidos aos 15 minutos, n&#227;o houve queda significativa da sensibilidade, sugerindo que o exame pudesse ter dura&#231;&#227;o mais curta. Al&#233;m disso, em compara&#231;&#227;o com estudos anteriores, foi encontrada elevada sensibilidade, o que os autores atribuem &#224; sele&#231;&#227;o de pacientes com forte suspeita cl&#237;nica de s&#237;ncope vasovagal.</p>
    <p>O &#237;ndice de falsos negativos no TI durante investiga&#231;&#227;o de s&#237;ncope vasovagal ainda &#233; significativo - chegando at&#233; 30%, quando se utiliza o nitrato<sup>14</sup>. Assim, novas drogas sensibilizantes devem ser testadas para reduzir esse &#237;ndice. Exames com resultados falsos positivos s&#227;o menos frequentes, mas os estudos mostram que em m&#233;dia 15% dos pacientes sem hist&#243;ria pr&#233;via de s&#237;ncope t&#234;m resultado positivo. O esclarecimento dos mecanismos envolvidos e dos limites entre a resposta fisiol&#243;gica e a resposta patol&#243;gica certamente facilitar&#225; a interpreta&#231;&#227;o do exame.</p>
    <p>Outros estudos s&#227;o necess&#225;rios tamb&#233;m para definir a utilidade do TI na avalia&#231;&#227;o progn&#243;stica e na programa&#231;&#227;o terap&#234;utica. J&#225; o uso no controle da resposta ao tratamento da SVV depende primeiramente da comprova&#231;&#227;o da efic&#225;cia do tratamento. Estudos randomizados e controlados mostraram que algumas medica&#231;&#245;es at&#233; pouco tempo bastante utilizadas e o uso de dispositivos implant&#225;veis n&#227;o s&#227;o eficazes na redu&#231;&#227;o dos eventos sincopais<sup>45,46,53</sup>. </p>
    <p>
      <bold>Conclus&#245;es</bold>
    </p>
    <p>O TI &#233; um exame &#250;til na investiga&#231;&#227;o da s&#237;ncope inexplicada. A utiliza&#231;&#227;o indiscriminada e sem crit&#233;rios metodol&#243;gicos bem demonstrados pode comprometer sua credibilidade e import&#226;ncia. </p>
    <p>O exame tem papel relevante no diagn&#243;stico diferencial e tem sido fundamental no entendimento das altera&#231;&#245;es hemodin&#226;micas relacionadas &#224;s disautonomias. Talvez, com a evolu&#231;&#227;o do conhecimento sobre a fisiopatologia e o tratamento dessas doen&#231;as, os resultados do TI possam ser utilizados tamb&#233;m na orienta&#231;&#227;o terap&#234;utica. </p>
    <p>A metodologia do TI vem sendo aprimorada ao longo do tempo. Assim, os protocolos propostos devem ser avaliados considerando-se os poss&#237;veis falsos positivos e falsos negativos, e o objetivo dos futuros estudos deve ser o desenvolvimento de m&#233;todos que apresentem melhor acur&#225;cia sem perda da especificidade. </p>
    <p>Concluindo, o TI &#233; um exame n&#227;o invasivo importante na avalia&#231;&#227;o diagn&#243;stica da s&#237;ncope inexplicada, mas apresenta limita&#231;&#245;es e algumas vezes n&#227;o &#233; capaz de definir o diagn&#243;stico. No entanto, essas imperfei&#231;&#245;es n&#227;o justificam o abandono do teste, mas a busca pelo aprimoramento da t&#233;cnica. Na pr&#225;tica cl&#237;nica, o TI tem seu lugar reconhecido, mas &#233; fundamental que a indica&#231;&#227;o seja criteriosa e que os protocolos obede&#231;am aos propostos nas normatiza&#231;&#245;es internacionais, para permitir a interpreta&#231;&#227;o correta dos resultados. </p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de disserta&#231;&#227;o de Mestrado de Paula Gon&#231;alves Macedo pela Universidade de Bras&#237;lia.</p>
    <p>
      <fn id="nt" fn-type="corresp">
        <label>
          <bold>Correspond&#234;ncia:</bold>
        </label>
        <p> Luiz R. Leite </p>
        <p> SMDB Conj 16 Lote 5 Casa A - Lago Sul </p>
        <p> 71680160 - Bras&#237;lia, DF - Brasil </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="leite.luiz@brturbo.com.br">leite.luiz@brturbo.com.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 21/06/09; revisado recebido em 01/12/09; aceito em 12/04/10.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Brignole M, Alboni P, Benditt DG, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, et al. Guidelines on management (diagnosis and treatment) of syncope--update 2004. Europace. 2004; 6 (6): 467-537.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Guidelines on management (diagnosis and treatment) of syncope: update 2004</article-title>
          <source>Europace</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>467</fpage>
          <lpage>537</lpage>
          <issue>6</issue>
          <volume>6</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Brignole</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Alboni</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Benditt</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Bergfeldt</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Blanc</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Bloch Thomsen</surname>
              <given-names>PE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Benditt DG, Sutton R. Tilt-table testing in the evaluation of syncope. J Cardiovasc Electrophysiol. 2005; 16 (3): 356-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Tilt-table testing in the evaluation of syncope</article-title>
          <source>J Cardiovasc Electrophysiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>356</fpage>
          <lpage>8</lpage>
          <issue>3</issue>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Benditt</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Sutton</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Petkar S, Fitzpatrick A. Tilt-table testing: transient loss of consciousness discriminator or epiphenomenon? Europace. 2008; 10 (6): 747-50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Tilt-table testing: transient loss of consciousness discriminator or epiphenomenon?</article-title>
          <source>Europace</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>747</fpage>
          <lpage>50</lpage>
          <issue>6</issue>
          <volume>10</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Petkar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fitzpatrick</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Sheldon R. Tilt testing for syncope: a reappraisal. Curr Opin Cardiol. 2005; 20 (1): 38-41.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Tilt testing for syncope: a reappraisal</article-title>
          <source>Curr Opin Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>38</fpage>
          <lpage>41</lpage>
          <issue>1</issue>
          <volume>20</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sheldon</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, et al. Guidelines for the diagnosis and management of syncope (version 2009): the Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). Eur Heart J. 2009; 30 (21): 2631-71.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Guidelines for the diagnosis and management of syncope (version 2009): the Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>2631</fpage>
          <lpage>71</lpage>
          <issue>21</issue>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Moya</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sutton</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ammirati</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Blanc</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Brignole</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dahm</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Strickberger SA, Benson DW, Biaggioni I, Callans DJ, Cohen MI, Ellenbogen KA, et al. AHA/ACCF Scientific Statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: in collaboration with the Heart Rhythm Society: endorsed by the American Autonomic Society. Circulation. 2006; 113 (2): 316-27.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>AHA/ACCF Scientific Statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: in collaboration with the Heart Rhythm Society: endorsed by the American Autonomic Society</article-title>
          <source>Circulation</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>316</fpage>
          <lpage>27</lpage>
          <issue>2</issue>
          <volume>113</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Strickberger</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Benson</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Biaggioni</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Callans</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Ellenbogen</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Benditt DG, Olshansky B, Wieling W. The ACCF/AHA scientific statement on syncope needs rethinking. J Am Coll Cardiol. 2006; 48 (12): 2598-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The ACCF/AHA scientific statement on syncope needs rethinking</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>2598</fpage>
          <lpage>9</lpage>
          <issue>12</issue>
          <volume>48</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Benditt</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Olshansky</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wieling</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Pachon JC, Pachon EI, Pachon JC, Lobo TJ, Pachon MZ, Vargas RN, et al. "Cardioneuroablation"--new treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablation. Europace. 2005 ;7(1):1-13.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>"Cardioneuroablation": new treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablation</article-title>
          <source>Europace</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>1</fpage>
          <lpage>13</lpage>
          <issue>1</issue>
          <volume>7</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pachon</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Pachon</surname>
              <given-names>EI</given-names>
            </name>
            <name>
              <surname>Pachon</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Lobo</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Pachon</surname>
              <given-names>MZ</given-names>
            </name>
            <name>
              <surname>Vargas</surname>
              <given-names>RN</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Aerts A, Dendale P, Strobel G, Pierre B. Sublingual nitrates during head-up tilt testing for the diagnosis of vasovagal syncope. Am Heart J. 1997; 133 (5): 504-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Sublingual nitrates during head-up tilt testing for the diagnosis of vasovagal syncope</article-title>
          <source>Am Heart J</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>504</fpage>
          <lpage>7</lpage>
          <issue>5</issue>
          <volume>133</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Aerts</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dendale</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Strobel</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pierre</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Raviele A, Menozzi C, Brignole M, Gasparini G, Alboni P, Musso G, et al. Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol. 1995; 76 (4): 267-72.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>267</fpage>
          <lpage>72</lpage>
          <issue>4</issue>
          <volume>76</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Raviele</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Menozzi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Brignole</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gasparini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Alboni</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Musso</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Oraii S, Maleki M, Minooii M, Kafaii P. Comparing two different protocols for tilt table testing: sublingual glyceryl trinitrate versus isoprenaline infusion. Heart. 1999; 81 (6): 603-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparing two different protocols for tilt table testing: sublingual glyceryl trinitrate versus isoprenaline infusion</article-title>
          <source>Heart</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>603</fpage>
          <lpage>5</lpage>
          <issue>6</issue>
          <volume>81</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Oraii</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Maleki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Minooii</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kafaii</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Fitzpatrick AP, Theodorakis G, Vardas P, Sutton R. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol. 1991; 17 (1): 125-30.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Methodology of head-up tilt testing in patients with unexplained syncope</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>125</fpage>
          <lpage>30</lpage>
          <issue>1</issue>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fitzpatrick</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Theodorakis</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vardas</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sutton</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Nava S, Mont L, Silva RM, Rogel U, Osorio P, Bartholomay E, et al. Short head-up tilt test potentiated with oral nitroglycerine: comparison with a conventional test using isoproterenol. Pacing Clin Electrophysiol. 2004; 27 (8): 1085-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Short head-up tilt test potentiated with oral nitroglycerine: comparison with a conventional test using isoproterenol</article-title>
          <source>Pacing Clin Electrophysiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1085</fpage>
          <lpage>8</lpage>
          <issue>8</issue>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nava</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mont</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Rogel</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Osorio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bartholomay</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Hermosillo AG, Marquez MF, Jauregui-Renaud K, Falcon JC, Casanova JM, Guevara M, et al. Tilt testing in neurocardiogenic syncope: isosorbide versus isoproterenol. Acta Cardiol. 2000; 55 (6): 351-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Tilt testing in neurocardiogenic syncope: isosorbide versus isoproterenol</article-title>
          <source>Acta Cardiol</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>351</fpage>
          <lpage>5</lpage>
          <issue>6</issue>
          <volume>55</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hermosillo</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Marquez</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Jauregui-Renaud</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Falcon</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Casanova</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Guevara</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Ammirati F, Colivicchi F, Biffi A, Magris B, Pandozi C, Santini M. Head-up tilt testing potentiated with low-dose sublingual isosorbide dinitrate: a simplified time-saving approach for the evaluation of unexplained syncope. Am Heart J. 1998; 135 (4): 671-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Head-up tilt testing potentiated with low-dose sublingual isosorbide dinitrate: a simplified time-saving approach for the evaluation of unexplained syncope</article-title>
          <source>Am Heart J</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>671</fpage>
          <lpage>6</lpage>
          <issue>4</issue>
          <volume>135</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ammirati</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Colivicchi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Biffi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Magris</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Pandozi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Santini</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Leman RB, Clarke E, Gillete P. Significant complications can occur with ischemic heart disease and tilt table testing. Pacing Clin Electrophysiol. 1999; 22 (4 pt 1): 675-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Significant complications can occur with ischemic heart disease and tilt table testing</article-title>
          <source>Pacing Clin Electrophysiol</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>675</fpage>
          <lpage>7</lpage>
          <issue>4 Pt 1</issue>
          <volume>22</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Leman</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Gillete</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Raviele A, Gasparini G, Di Pede F, Menozzi C, Brignole M, Dinelli M, et al. Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope. Am Heart J. 1994; 127 (1): 103-11.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope</article-title>
          <source>Am Heart J</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>103</fpage>
          <lpage>11</lpage>
          <issue>1</issue>
          <volume>127</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Raviele</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gasparini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Di Pede</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Menozzi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Brignole</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dinelli</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Del Rosso A, Bartoli P, Bartoletti A, Brandinelli-Geri A, Bonechi F, Maioli M, et al. Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. Am Heart J. 1998; 135 (4): 564-70.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope</article-title>
          <source>Am Heart J</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>564</fpage>
          <lpage>70</lpage>
          <issue>4</issue>
          <volume>135</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Del Rosso</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bartoli</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bartoletti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brandinelli-Geri</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bonechi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Maioli</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Brito FS, Maia I, Gizzi J, Fagundes M, Lorga A, Rassi A, et al. Sociedade Brasileira de Cardiologia. Diretrizes para avalia&#231;&#227;o e tratamento de pacientes com arritmias cardiacas. Arq Bras Cardiol. 2002; 79 (supl. V): 1-50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Sociedade Brasileira de Cardiologia: Diretrizes para avalia&#231;&#227;o e tratamento de pacientes com arritmias cardiacas</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>1</fpage>
          <lpage>50</lpage>
          <volume>79</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Brito</surname>
              <given-names>FS</given-names>
            </name>
            <name>
              <surname>Maia</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Gizzi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fagundes</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lorga</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rassi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Aerts AJ. Nitrate stimulated tilt table testing: a review of the literature. Pacing Clin Electrophysiol. 2003; 26 (7 Pt 1): 1528-37.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Nitrate stimulated tilt table testing: a review of the literature</article-title>
          <source>Pacing Clin Electrophysiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1528</fpage>
          <lpage>37</lpage>
          <issue>7 Pt 1</issue>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Aerts</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Koole MA, Aerts A, Praet J, Franken P, Dendale P, Block P. Venous pooling during nitrate-stimulated tilt testing in patients with vasovagal syncope. Europace. 2000; 2 (4): 343-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Venous pooling during nitrate-stimulated tilt testing in patients with vasovagal syncope</article-title>
          <source>Europace</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>343</fpage>
          <lpage>5</lpage>
          <issue>4</issue>
          <volume>2</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Koole</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Aerts</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Praet</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Franken</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Dendale</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Block</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Noll GWR, de Marchi S, Shaw S, Luscher TF. Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers. Circulation. 1997; 95 (9): 2286-92.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers</article-title>
          <source>Circulation</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>2286</fpage>
          <lpage>92</lpage>
          <issue>9</issue>
          <volume>95</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Noll</surname>
              <given-names>GWR</given-names>
            </name>
            <name>
              <surname>de Marchi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Luscher</surname>
              <given-names>TF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Benditt DG, Ferguson DW, Grubb BP, Kapoor WN, Kugler J, Lerman BB, et al. Tilt table testing for assessing syncope. American College of Cardiology. J Am Coll Cardiol. 1996; 28 (1): 263-75.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Tilt table testing for assessing syncope: American College of Cardiology</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>263</fpage>
          <lpage>75</lpage>
          <issue>1</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Benditt</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Ferguson</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Grubb</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Kapoor</surname>
              <given-names>WN</given-names>
            </name>
            <name>
              <surname>Kugler</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lerman</surname>
              <given-names>BB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Puggioni E, Guiducci V, Brignole M, Menozzi C, Oddone D, Donateo P, et al. Results and complications of the carotid sinus massage performed according to the "method of symptoms". Am J Cardiol. 2002; 89 (5): 599-601.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Results and complications of the carotid sinus massage performed according to the "method of symptoms"</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>599</fpage>
          <lpage>601</lpage>
          <issue>5</issue>
          <volume>89</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Puggioni</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Guiducci</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Brignole</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Menozzi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Oddone</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Donateo</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Wu TC, Hachul D, Scanavacca M, Sosa E. Comparison between tilt-table testing results performed during different periods of the day. Arq Bras Cardiol. 2002; 79 (4): 385-94.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparison between tilt-table testing results performed during different periods of the day</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>385</fpage>
          <lpage>94</lpage>
          <issue>4</issue>
          <volume>79</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Hachul</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Scanavacca</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sosa</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Graham LA, Gray JC, Kenny RA. Comparison of provocative tests for unexplained syncope: isoprenaline and glyceryl trinitrate for diagnosing vasovagal syncope. Eur Heart J. 2001; 22 (6):*/ 497-503.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparison of provocative tests for unexplained syncope: isoprenaline and glyceryl trinitrate for diagnosing vasovagal syncope</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>497</fpage>
          <lpage>503</lpage>
          <issue>6</issue>
          <volume>22</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Graham</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Gray</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Kenny</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Prakash ES, Madanmohan, Narayan SK, Prashanth U, Kamath MG, Udupa K, et al. Tilt table testing in the diagnostic evaluation of presyncope and syncope: a case-series report. Indian J Physiol Pharmacol. 2004; 48 (2): 213-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Tilt table testing in the diagnostic evaluation of presyncope and syncope: a case-series report</article-title>
          <source>Indian J Physiol Pharmacol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>213</fpage>
          <lpage>8</lpage>
          <issue>2</issue>
          <volume>48</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Prakash</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Madanmohan</surname>
            </name>
            <name>
              <surname>Narayan</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Prashanth</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Kamath</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Udupa</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Aerts AJ, Dendale P. Diagnostic value of nitrate stimulated tilt testing without preceding passive tilt in patients with suspected vasovagal syncope and a healthy control group. Pacing Clin Electrophysiol. 2005; 28 (1): 29-32.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Diagnostic value of nitrate stimulated tilt testing without preceding passive tilt in patients with suspected vasovagal syncope and a healthy control group</article-title>
          <source>Pacing Clin Electrophysiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>29</fpage>
          <lpage>32</lpage>
          <issue>1</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Aerts</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Dendale</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling W, et al. Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope. Eur Heart J. 2006; 27 (18): 2232-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>2232</fpage>
          <lpage>9</lpage>
          <issue>18</issue>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Brignole</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sutton</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Menozzi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Garcia-Civera</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Moya</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wieling</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. Carew S, Connor MO, Cooke J, Conway R, Sheehy C, Costelloe A, et al. A review of postural orthostatic tachycardia syndrome. Europace. 2009; 11 (1): 18-25.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A review of postural orthostatic tachycardia syndrome</article-title>
          <source>Europace</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>18</fpage>
          <lpage>25</lpage>
          <issue>1</issue>
          <volume>11</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Carew</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Connor</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>Cooke</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Conway</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sheehy</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Costelloe</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31. Brignole M, Menozzi C, Del Rosso A, Costa S, Gaggioli G, Bottoni N, et al. New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge. Vasovagal Syncope International Study. Europace. 2000; 2 (1): 66-76.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge. Vasovagal Syncope International Study</article-title>
          <source>Europace</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>66</fpage>
          <lpage>76</lpage>
          <issue>1</issue>
          <volume>2</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Brignole</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Menozzi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Del Rosso</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gaggioli</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bottoni</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <mixed-citation>32. Freeman R. Clinical practice: neurogenic orthostatic hypotension. N Engl J Med. 2008; 358 (6): 615-24.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Clinical practice: neurogenic orthostatic hypotension</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>615</fpage>
          <lpage>24</lpage>
          <issue>6</issue>
          <volume>358</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Freeman</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B33">
        <mixed-citation>33. Jhanjee R, van Dijk JG, Sakaguchi S, Benditt DG. Syncope in adults: terminology, classification, and diagnostic strategy. Pacing Clin Electrophysiol. 2006; 29 (10): 1160-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Syncope in adults: terminology, classification, and diagnostic strategy</article-title>
          <source>Pacing Clin Electrophysiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>1160</fpage>
          <lpage>9</lpage>
          <issue>10</issue>
          <volume>29</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jhanjee</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>van Dijk</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Sakaguchi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Benditt</surname>
              <given-names>DG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B34">
        <mixed-citation>34. Gieroba ZJ, Newton JL, Parry SW, Norton M, Lawson J, Kenny RA. Unprovoked and glyceryl trinitrate-provoked head-up tilt table test is safe in older people: a review of 10 years experience. J Am Geriatr Soc. 2004; 52 (11): 1913-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Unprovoked and glyceryl trinitrate-provoked head-up tilt table test is safe in older people: a review of 10 years' experience</article-title>
          <source>J Am Geriatr Soc</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1913</fpage>
          <lpage>5</lpage>
          <issue>11</issue>
          <volume>52</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gieroba</surname>
              <given-names>ZJ</given-names>
            </name>
            <name>
              <surname>Newton</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Parry</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Norton</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lawson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kenny</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B35">
        <mixed-citation>35. Baron-Esquivias G, Pedrote A, Cayuela A, Valle JI, Fernandez JM, Estepa MJ, et al. Age and gender differences in basal and isoprenaline protocols for head-up tilt table testing. Europace. 2001; 3 (2): 136-40.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Age and gender differences in basal and isoprenaline protocols for head-up tilt table testing</article-title>
          <source>Europace</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>136</fpage>
          <lpage>40</lpage>
          <issue>2</issue>
          <volume>3</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Baron-Esquivias</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pedrote</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cayuela</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Valle</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Fernandez</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Estepa</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B36">
        <mixed-citation>36. Maloney JD, Jaeger FJ, Fouad-Tarazi FM, Morris HH. Malignant vasovagal syncope: prolonged asystole provoked by head-up tilt: case report and review of diagnosis, pathophysiology, and therapy. Cleve Clin J Med. 1988; 55 (6): 542-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Malignant vasovagal syncope: prolonged asystole provoked by head-up tilt: case report and review of diagnosis, pathophysiology, and therapy</article-title>
          <source>Cleve Clin J Med</source>
          <date>
            <year>1988</year>
          </date>
          <fpage>542</fpage>
          <lpage>8</lpage>
          <issue>6</issue>
          <volume>55</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Maloney</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Jaeger</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Fouad-Tarazi</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>HH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B37">
        <mixed-citation>37. Kapoor W, Brant N. Evaluation of syncope by upright tilt testing with isoproterenol: a nonspecific test. Ann Intern Med. 1992; 116 (5): 358-63.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Evaluation of syncope by upright tilt testing with isoproterenol: a nonspecific test</article-title>
          <source>Ann Intern Med</source>
          <date>
            <year>1992</year>
          </date>
          <fpage>358</fpage>
          <lpage>63</lpage>
          <issue>5</issue>
          <volume>116</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kapoor</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Brant</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B38">
        <mixed-citation>38. Bartoletti A, Gaggioli G, Menozzi C, Bottoni N, Del Rosso A, Mureddu R, et al. Head-up tilt testing potentiated with oral nitroglycerin: a randomized trial of the contribution of a drug-free phase and a nitroglycerin phase in the diagnosis of neurally mediated syncope. Europace. 1999; 1 (3): 183-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Head-up tilt testing potentiated with oral nitroglycerin: a randomized trial of the contribution of a drug-free phase and a nitroglycerin phase in the diagnosis of neurally mediated syncope</article-title>
          <source>Europace</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>183</fpage>
          <lpage>6</lpage>
          <issue>3</issue>
          <volume>1</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bartoletti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gaggioli</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Menozzi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bottoni</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Del Rosso</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mureddu</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B39">
        <mixed-citation>39. Hachul D, Scanavacca M, Sosa E. Does a role exist for tilting-guided therapy in the management of neurocardiogenic syncope? Arq Bras Cardiol. 2002; 78 (2): 167-71.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Does a role exist for tilting-guided therapy in the management of neurocardiogenic syncope</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>167</fpage>
          <lpage>71</lpage>
          <issue>2</issue>
          <volume>78</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hachul</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Scanavacca</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sosa</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B40">
        <mixed-citation>40. Bastos S, Scanavacca M, Darrieux F, Ludovice AC, Sosa E, Hachul DT. Clinical outcome of patients with neurocardiogenic syncope (NCS) after therapy interruption. Arq Bras Cardiol. 2006; 86 (4): 256-60.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Clinical outcome of patients with neurocardiogenic syncope (NCS) after therapy interruption</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>256</fpage>
          <lpage>60</lpage>
          <issue>4</issue>
          <volume>86</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bastos</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Scanavacca</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Darrieux</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ludovice</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Sosa</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hachul</surname>
              <given-names>DT</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B41">
        <mixed-citation>41. Grimm W, Degenhardt M, Hoffman J, Menz V, Wirths A, Maisch B. Syncope recurrence can better be predicted by history than by head-up tilt testing in untreated patients with suspected neurally mediated syncope. Eur Heart J. 1997; 18 (9): 1465-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Syncope recurrence can better be predicted by history than by head-up tilt testing in untreated patients with suspected neurally mediated syncope</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>1465</fpage>
          <lpage>9</lpage>
          <issue>9</issue>
          <volume>18</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Grimm</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Degenhardt</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Menz</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Wirths</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Maisch</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B42">
        <mixed-citation>42. Sheldon R, Rose S, Koshman ML. Comparison of patients with syncope of unknown cause having negative or positive tilt-table tests. Am J Cardiol. 1997; 80 (5): 581-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparison of patients with syncope of unknown cause having negative or positive tilt-table tests</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>581</fpage>
          <lpage>5</lpage>
          <issue>5</issue>
          <volume>80</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sheldon</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rose</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Koshman</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B43">
        <mixed-citation>43. Moya A, Brignole M, Menozzi C, Garcia-Civera R, Tognarini S, Mont L, et al. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation. 2001; 104 (11): 1261-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope</article-title>
          <source>Circulation</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>1261</fpage>
          <lpage>7</lpage>
          <issue>11</issue>
          <volume>104</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Moya</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brignole</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Menozzi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Garcia-Civera</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tognarini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mont</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B44">
        <mixed-citation>44. Aydin MA, Maas R, Mortensen K, Steinig T, Klemm H, Risius T, et al. Predicting recurrence of vasovagal syncope: a simple risk score for the clinical routine. J Cardiovasc Electrophysiol. 2009; 20 (4): 416-21.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Predicting recurrence of vasovagal syncope: a simple risk score for the clinical routine</article-title>
          <source>J Cardiovasc Electrophysiol</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>416</fpage>
          <lpage>21</lpage>
          <issue>4</issue>
          <volume>20</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Aydin</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Maas</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mortensen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Steinig</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Klemm</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Risius</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B45">
        <mixed-citation>45. Sheldon R, Connolly S, Rose S, Klingenheben T, Krahn A, Morillo C, et al. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation. 2006; 113 (9): 1164-70.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope</article-title>
          <source>Circulation</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>1164</fpage>
          <lpage>70</lpage>
          <issue>9</issue>
          <volume>113</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sheldon</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Connolly</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rose</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Klingenheben</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Krahn</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Morillo</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B46">
        <mixed-citation>46. Madrid AH, Ortega J, Rebollo JG, Manzano JG, Segovia JG, Sanchez A, et al. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. J Am Coll Cardiol. 2001; (2): 554-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>554</fpage>
          <lpage>9</lpage>
          <issue>2</issue>
          <person-group person-group-type="author">
            <name>
              <surname>Madrid</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Ortega</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rebollo</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Manzano</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Segovia</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Sanchez</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B47">
        <mixed-citation>47. Tan MPP, Parry SW. Vasovagal syncope in the older patient. J Am Coll Cardiol. 2008; 51 (6): 599-606.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Vasovagal syncope in the older patient</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>599</fpage>
          <lpage>606</lpage>
          <issue>6</issue>
          <volume>51</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Tan</surname>
              <given-names>MPP</given-names>
            </name>
            <name>
              <surname>Parry</surname>
              <given-names>SW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B48">
        <mixed-citation>48. Romme JJ, van Dijk N, Boer KR, Dekker LR, Stam J, Reitsma JB, et al. Influence of age and gender on the occurrence and presentation of reflex syncope. Clin Auton Res. 2008; 18 (3): 127-33.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Influence of age and gender on the occurrence and presentation of reflex syncope</article-title>
          <source>Clin Auton Res</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>127</fpage>
          <lpage>33</lpage>
          <issue>3</issue>
          <volume>18</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Romme</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>van Dijk</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Boer</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Dekker</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Stam</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Reitsma</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B49">
        <mixed-citation>49. Brignole M. Distinguishing syncopal from non-syncopal causes of fall in older people. Age and Ageing. 2006; 35 (S2): ii46-ii50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Distinguishing syncopal from non-syncopal causes of fall in older people</article-title>
          <source>Age and Ageing</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>ii46</fpage>
          <lpage>ii50</lpage>
          <issue>S2</issue>
          <volume>35</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Brignole</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B50">
        <mixed-citation>50. Edfors R, Erdal J, A-Rogvi-Hansen B. Tilt table testing in patients with suspected epilepsy. Acta Neurol Scand. 2008; 117 (5): 354-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Tilt table testing in patients with suspected epilepsy</article-title>
          <source>Acta Neurol Scand</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>354</fpage>
          <lpage>8</lpage>
          <issue>5</issue>
          <volume>117</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Edfors</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Erdal</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>A-Rogvi-Hansen</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B51">
        <mixed-citation>51. Zaidi A, Crampton S, Clough P, Fitzpatrick A, Scheepers B. Head-up tilting is a useful provocative test for psychogenic non-epileptic seizures. Seizure. 1999; 8 (6): 353-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Head-up tilting is a useful provocative test for psychogenic non-epileptic seizures</article-title>
          <source>Seizure</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>353</fpage>
          <lpage>5</lpage>
          <issue>6</issue>
          <volume>8</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Zaidi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Crampton</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Clough</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fitzpatrick</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Scheepers</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B52">
        <mixed-citation>52. Aerts A, Dendale P, Block P. Influence of tilt duration on diagnostic value in sublingual nitrate stimulated head-up tilt testing. (abstract). Acta Cardiol. 1997; 52 (Suppl.): 568.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Influence of tilt duration on diagnostic value in sublingual nitrate stimulated head-up tilt testing</article-title>
          <source>Acta Cardiol</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>568</fpage>
          <volume>52</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Aerts</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dendale</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Block</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B53">
        <mixed-citation>53. Raviele A, Giada F, Menozzi C, Speca G, Orazi S, Gasparini G, et al. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J. 2004; 25 (19): 1741-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope: The vasovagal syncope and pacing trial (SYNPACE)</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1741</fpage>
          <lpage>8</lpage>
          <issue>19</issue>
          <volume>25</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Raviele</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Giada</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Menozzi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Speca</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Orazi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gasparini</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Test de inclinaci&#243;n (Tilt-test): de lo necesario a lo imprescindible</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>El test de inclinaci&#243;n (TI) es muy utilizado para la investigaci&#243;n de s&#237;ncopes y pres&#237;ncopes, pues posibilita el diagn&#243;stico de diferentes tipos de disautonom&#237;as. La principal causa de s&#237;ncope es el S&#237;ndrome Vasovagal, cuyo diagn&#243;stico es el m&#225;s frecuente entre las indicaciones de TI. EL examen es utilizado hace cerca de 20 a&#241;os, pero muchos m&#233;dicos desconocen la metodolog&#237;a. Son importantes la indicaci&#243;n apropiada, despu&#233;s de exclusi&#243;n de causas card&#237;acas de s&#237;ncope, y la orientaci&#243;n del paciente para garantizar la tranquilidad y la seguridad del test. Existen controversias en la literatura sobre la capacidad diagn&#243;stica y la confiabilidad de los resultados. Los estudios con protocolos diversos pueden explicar la variabilidad de los resultados. En esta revisi&#243;n, son colocadas las indicaciones y la metodolog&#237;a recomendadas por las directrices, complicaciones, limitaciones y perspectivas de ese examen.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Test de inclinaci&#243;n</kwd>
        <kwd>s&#237;ncope</kwd>
        <kwd>s&#237;ncope vasovagal</kwd>
        <kwd>protocolos cl&#237;nicos</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO DE REVISI&#211;N</bold>
      </p>
      <p>
        <fn id="enda-body2">
          <label>
            <bold>Test de inclinaci&#243;n (<italic>Tilt-test</italic>) - de lo necesario a lo imprescindible</bold>
          </label>
          <p>
            <bold>Paula Gon&#231;alves Macedo<sup>II,III</sup>; Luiz R. Leite<sup>II</sup>; Leopoldo Santos-Neto<sup>III</sup>; Denise Hachul<sup>I</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Faculdade de Medicina da Universidade de S&#227;o Paulo, S&#227;o Paulo, SP</p>
      <p><sup>III</sup>Centro de Fibrila&#231;&#227;o Atrial do Distrito Federal - Hospital de Base</p>
      <p><sup>II</sup>Universidade de Bras&#237;lia, DF - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p>El test de inclinaci&#243;n (TI) es muy utilizado para la investigaci&#243;n de s&#237;ncopes y pres&#237;ncopes, pues posibilita el diagn&#243;stico de diferentes tipos de disautonom&#237;as. La principal causa de s&#237;ncope es el S&#237;ndrome Vasovagal, cuyo diagn&#243;stico es el m&#225;s frecuente entre las indicaciones de TI. EL examen es utilizado hace cerca de 20 a&#241;os, pero muchos m&#233;dicos desconocen la metodolog&#237;a. Son importantes la indicaci&#243;n apropiada, despu&#233;s de exclusi&#243;n de causas card&#237;acas de s&#237;ncope, y la orientaci&#243;n del paciente para garantizar la tranquilidad y la seguridad del test. Existen controversias en la literatura sobre la capacidad diagn&#243;stica y la confiabilidad de los resultados. Los estudios con protocolos diversos pueden explicar la variabilidad de los resultados. En esta revisi&#243;n, son colocadas las indicaciones y la metodolog&#237;a recomendadas por las directrices, complicaciones, limitaciones y perspectivas de ese examen.</p>
      <p><bold>Palabras clave:</bold> Test de inclinaci&#243;n, s&#237;ncope, s&#237;ncope vasovagal, protocolos cl&#237;nicos.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>El test de inclinaci&#243;n (TI) oTilt test es un m&#233;todo muy utilizado para la investigaci&#243;n de s&#237;ncope, pres&#237;ncopes, mareos, palpitaciones relacionadas al ortostatismo y cuadros disauton&#243;micos<sup>1</sup>. Mientras tanto, la principal indicaci&#243;n ha sido la investigaci&#243;n del S&#237;ndrome Vasovagal (SVV). </p>
      <p>En 1986, Kenny et al. <sup>2</sup> reportaron, por la primera vez, la utilidad del TI en la investigaci&#243;n de pacientes con s&#237;ncope de probable origen vasovagal. Observaron que la exposici&#243;n a la inclinaci&#243;n de 60&#186; por 60 minutos desencadenaba el reflejo vasovagal en 66% de los pacientes con s&#237;ncope de origen inexplicado. Desde entonces, viene siendo testeados protocolos de menor duraci&#243;n o asociados a drogas, con el objetivo de aumentar la sensibilidad y abreviar el tiempo de ejecuci&#243;n del test. </p>
      <p>Recientemente, el examen ha recibido cr&#237;ticas debido a las tasas de sensibilidad y especificidad muy variables en los diferentes estudios. Adem&#225;s de eso, el resultado del TI no tiene implicaci&#243;n terap&#233;utica bien definida, y la reproductibilidad es limitada<sup>3,4</sup>. </p>
      <p>La Directriz Europea de S&#237;ncope, actualizada en 2009, describe las recomendaciones de la metodolog&#237;a y de las indicaciones del examen y los tipos de respuesta esperados<sup>5</sup>. En este art&#237;culo, discutiremos las actuales indicaciones, protocolos, limitaciones y perspectivas de ese examen. </p>
      <p>
        <bold>Indicaciones del test de inclinaci&#243;n</bold>
      </p>
      <p>El Consenso Americano de S&#237;ncope de 2006 no recomienda el TI para evaluaci&#243;n de s&#237;ncope, sin embargo ese documento recibi&#243; muchas cr&#237;ticas que ser&#225;n comentadas m&#225;s adelante<sup>6,7</sup>. En la pr&#225;ctica cl&#237;nica, se utilizan las indicaciones preconizadas por la Directriz Europea de S&#237;ncope<sup>5</sup>. Esa directriz establece que el TI sea realizado para fines diagn&#243;sticos en las siguientes situaciones. </p>
      <p>
        <bold>Recomendaci&#243;n Clase I</bold>
      </p>
      <p>En pacientes j&#243;venes, sin enfermedad card&#237;aca evidente o sospechada, con s&#237;ncopes recurrentes de origen inexplicado, en los cuales la historia no es suficientemente t&#237;pica para el diagn&#243;stico de s&#237;ncope neuromediado. </p>
      <p>En casos de episodio &#250;nico de s&#237;ncope inexplicado, ocurrido en situaci&#243;n de alto riesgo de trauma f&#237;sico o con implicaciones ocupacionales; o en casos de s&#237;ncope recurrente en ausencia de cardiopat&#237;a, o aun, si en paciente portador de cardiopat&#237;a, fuesen excluidas las causas card&#237;acas de s&#237;ncope. </p>
      <p>En casos en que la demostraci&#243;n de la susceptibilidad al s&#237;ncope neuromediado tuviese relevancia cl&#237;nica. </p>
      <p>
        <bold>Recomendaci&#243;n Clase II</bold>
      </p>
      <p>Cuando la comprensi&#243;n del <italic>gold standard</italic> de respuesta hemodin&#225;mica durante la s&#237;ncope pueda alterar la programaci&#243;n terap&#233;utica. </p>
      <p>En la diferenciaci&#243;n de s&#237;ncope convulsivo y epilepsia. </p>
      <p>En el diagn&#243;stico diferencial entre s&#237;ncope reflejo e hipotensi&#243;n ortost&#225;tica. </p>
      <p>Para la evaluaci&#243;n de pacientes con ca&#237;das recurrentes inexplicadas. </p>
      <p>En el abordaje de pacientes con pres&#237;ncope o mareos recurrentes. </p>
      <p>En la evaluaci&#243;n de pacientes con s&#237;ncopes recurrentes y enfermedades psiqui&#225;tricas. </p>
      <p>La directriz europea afirma que, en los casos en que el examen es recomendado y en la ausencia de cardiopat&#237;a asociada, el resultado positivo con reproducci&#243;n del s&#237;ncope espont&#225;neo es suficiente para definir el diagn&#243;stico de s&#237;ncope neuromediado. </p>
      <p>La realizaci&#243;n de TI para control de tratamiento o seguimiento de la SVV a largo plazo no ha sido recomendada. A pesar de que la directriz europea de s&#237;ncope no recomienda la realizaci&#243;n del TI en pacientes con historia cl&#237;nica t&#237;pica de SVV, el test de inclinaci&#243;n tiene valor en la identificaci&#243;n del tipo de SVV (cardioinhibitorio, vasodepresor o mixto). Algunos autores recomiendan diferentes opciones terap&#233;uticas dependiendo del tipo de s&#237;ncope vasovagal, por lo tanto, en ese caso, el TI servir&#237;a como orientaci&#243;n terap&#233;utica<sup>5,8</sup>. Pachon et al. <sup>8</sup> recientemente publicaron una nueva alternativa terap&#233;utica para los pacientes con s&#237;ncope neurocardiog&#233;nico, que ser&#237;a m&#225;s indicado para los pacientes con SVV del tipo cardioinhibitorio. </p>
      <p>
        <bold>Protocolos</bold>
      </p>
      <p>En las descripciones de los protocolos ya testeados, los t&#233;rminos "sensibilidad" y "positividad" se confunden debido a la inexistencia de un test <italic>gold standard</italic> para diagn&#243;stico de la SVV. Cuando se considera el diagn&#243;stico cl&#237;nico como <italic>gold standard</italic>, se ha utilizado el t&#233;rmino "sensibilidad del TI", ya que el paciente portador de la enfermedad fue seleccionado por medio de la historia cl&#237;nica. Cuando el examen es realizado en pacientes con s&#237;ncope inexplicado, el t&#233;rmino "positividad" es generalmente aplicado. Con todo, en esta revisi&#243;n, fue estandarizado el t&#233;rmino "sensibilidad" para ambas situaciones, con el objetivo de simplificar la descripci&#243;n de los estudios, pero se entiende que, en muchos casos, el t&#233;rmino representa apenas la positividad del examen. La utilizaci&#243;n del diagn&#243;stico cl&#237;nico como <italic>gold standard</italic> est&#225; sujeta a cr&#237;ticas debido a la subjetividad inherente al juzgamiento m&#233;dico, entre tanto, hasta el momento, ning&#250;n otro m&#233;todo demostr&#243; mayor precisi&#243;n. </p>
      <p>Inicialmente, los autores recomendaban apenas la inclinaci&#243;n ortost&#225;tica por tiempo prolongado, sin uso de drogas, denominado protocolo pasivo prolongado. En el an&#225;lisis de cinco estudios que evaluaron el resultado de la exposici&#243;n a la ortostasis pasiva, con duraci&#243;n m&#237;nima de 40 minutos, los &#237;ndices de sensibilidad observados fueron 13%, 25%, 31%, 35% y 75% (mediana de 31%)<sup>9-12</sup>. En contrapartida a la baja sensibilidad, la especificidad fue de 100%, 100%, 95%, 92% y 89%, respectivamente (media de 95%). </p>
      <p>En la tentativa de aumentar la precisi&#243;n diagn&#243;stica del TI, fue testeada la administraci&#243;n de diversas drogas sensibilizantes despu&#233;s de la fase pasiva, cuando el resultado de &#233;sta era negativo. </p>
      <p>Actualmente, el isoproterenol y el nitrato son las drogas m&#225;s utilizadas para ese fin. En los diversos estudios realizados, la sensibilidad del test con nitrato vari&#243; entre 57,5% y 87%, y la especificidad, entre 70% y 100%, mientras que el test con isoproterenol present&#243; variaciones entre 42% y 69% y entre 70 y 90%, respectivamente<sup>9,11,13-15</sup>. EL isoproterenol viene siendo abandonado debido a la menor sensibilidad, a los inconvenientes del acceso endovenoso y de los efectos colaterales, principalmente en pacientes con cardiopat&#237;a isqu&#233;mica<sup>16</sup> (<xref ref-type="table" rid="es_a12tab01m-body2">Tabla 1</xref>). </p>
      <p content-type="asset">
        <table-wrap id="es_a12tab01m-body2">
          <graphic xlink:href="1678-4170-abc-96-03-0246-00006-gt01-es.jpg"/></table-wrap>
      </p>
      <p>Inicialmente, el nitrato fue utilizado bajo la forma de nitroglicerina endovenosa, con sensibilidad de 53% y especificidad de 92%, consider&#225;ndose apenas la fase sensibilizada<sup>17</sup>. En estudio posterior, los mismos investigadores evaluaron el efecto de la nitroglicerina sublingual<sup>10</sup>. Inicialmente, los pacientes eran sometidos a la inclinaci&#243;n de 60&#186; por 45 minutos (inclinaci&#243;n pasiva), lo que resultaba en baja sensibilidad (25%) y elevada especificidad (100%). Despu&#233;s de administraci&#243;n de 300 mg de nitroglicerina sublingual, era observada respuesta positiva en m&#225;s de 26% de los pacientes y en 6% del grupo control, resultando en una especificidad de 94%. Datos semejantes fueron presentados por otros autores en los a&#241;os siguientes<sup>9,15,18</sup> (<xref ref-type="table" rid="es_a12tab01m-body2">Tabla 1</xref>). </p>
      <p>La directriz europea de s&#237;ncope, publicada en 2004, relata un an&#225;lisis de estudios que utilizaron 20 o 45 minutos de fase pasiva seguida por sensibilizaci&#243;n con nitrato y concluye que la sensibilidad de los ex&#225;menes con menor o mayor duraci&#243;n es semejante (69% versus 62%) sin disminuci&#243;n de la especificidad (94% para los protocolos con 20 minutos de fase pasiva)<sup>1</sup>. Desde entonces, se recomienda que el TI sea constituido por 20 minutos de fase pasiva y 20 minutos de fase sensibilizada (nitroglicerina o isoproterenol). De ese modo, el protocolo cl&#225;sico (sin uso de drogas sensibilizantes) viene siendo sustituido por el protocolo que combina la fase pasiva seguida por fase sensibilizada. </p>
      <p>En el Brasil, la nitroglicerina sublingual no es comercializada desde 2002, as&#237;, el vasodilatador utilizado es el dinitrato de isosorbida, en la dosis de 1,25 mg (1/4 del comprimido de uso sublingual), seg&#250;n recomendaci&#243;n de las Directrices para Evaluaci&#243;n y Tratamiento de Pacientes con Arritmias Card&#237;acas, publicada en 2002<sup>19</sup>. En tres estudios que evaluaron el uso de ese medicamento durante el TI, la sensibilidad oscil&#243; de 57 a 87%, y la especificidad, de 70 a 100%<sup>9,14,15</sup>. La dosis de 1,25 mg fue evaluada en apenas uno de esos estudios y fue aquella asociada a la mayor especificidad (100%)<sup>15</sup>. </p>
      <p>La sensibilizaci&#243;n del examen con uso de nitrato reproduce los mismos tipos de respuesta vasovagal de la inclinaci&#243;n pasiva: cardioinhibitoria, vasodepresora y mixta<sup>20</sup>. Entre tanto, el mecanismo por el cual el nitrato induce s&#237;ncope vasovagal no est&#225; aun esclarecido, y las hip&#243;tesis m&#225;s estudiadas ha sido: 1. vasodilataci&#243;n; 2. activaci&#243;n del sistema nervioso simp&#225;tico; 3. acci&#243;n directa en el sistema nervioso central (SNC); y 4. Acci&#243;n en el sistema nervioso central (SNC) v&#237;a neurohormonas<sup>20-22</sup>. </p>
      <p>
        <bold>Metodolog&#237;a recomendada</bold>
      </p>
      <p>El TI debe ser realizado en ambiente tranquilo, con poca iluminaci&#243;n y temperatura agradable. El control es hecho por m&#233;dico y auxiliar de enfermer&#237;a, entrenados para la realizaci&#243;n del examen, y no se recomienda permanencia de familiares. La sala debe ser equipada con material de reanimaci&#243;n cardiovascular, aunque la utilizaci&#243;n sea raramente necesaria<sup>19</sup>. El paciente debe estar en ayuno m&#237;nimo de cuatro horas para l&#237;quidos y seis horas para s&#243;lidos y debe permanecer acostado previamente a la inclinaci&#243;n por, por al menos, diez minutos<sup>19</sup>. Se debe evitar punci&#243;n venosa en esa fase, pero si fuese necesario, el tiempo de reposo preexamen debe ser aumentado para al menos 20 minutos<sup>1</sup>. La mesa del examen dispone de soporte para los pies y cinturones de seguridad y es inclinable hasta 60 o 70 grados (<xref ref-type="fig" rid="es_a12fig01m-body2">Figura 1</xref>). Angulaciones encima y abajo de aquella estandarizada presentan, respectivamente, menor sensibilidad y menor especificidad del TI<sup>1,23</sup>. Durante todo el examen, el paciente es monitoreado por electrocardiograma y medidas de la presi&#243;n arterial (PA). Lo ideal es el monitoreo continuo y no invasiva de la PA. Si la PA fuese evaluada intermitentemente, el intervalo entre las mediciones debe ser el menor posible, especialmente en la fase pr&#243;xima a la positivizaci&#243;n del examen. En pacientes con edad encima de 40 a&#241;os y historia cl&#237;nica de s&#237;ncope, es recomendado tambi&#233;n el masaje de los senos carot&#237;deos, pues, durante la ortostasis, la sensibilidad de esa t&#233;cnica es mayor, siendo posible aun evaluar el componente vasodepresor<sup>24</sup>. El examen puede ser realizado en cualquier per&#237;odo del d&#237;a, pero, cuando el objetivo fuese estudiar la reproductibilidad de los resultados, es importante repetir el examen en el mismo horario en que fue realizado previamente<sup>25</sup>. </p>
      <p content-type="asset">
        <fig id="es_a12fig01m-body2">
          <graphic xlink:href="1678-4170-abc-96-03-0246-00006-gf01-es.jpg"/></fig>
      </p>
      <p>
        <bold>Tipos de respuesta al test de inclinaci&#243;n</bold>
      </p>
      <p>Las Directrices para Evaluaci&#243;n y Tratamiento de Pacientes con Arritmias Card&#237;acas considera el criterio de positividad del TI cuando ocurre reproducci&#243;n de los s&#237;ntomas espont&#225;neos asociada al colapso hemodin&#225;mico<sup>19</sup>. Existe controversia en cuanto a la interrupci&#243;n del examen antes de que el paciente presente el s&#237;ncope. Muchos autores consideran que es suficiente interrumpir el TI cuando el m&#233;dico considera que la p&#233;rdida de conciencia es inminente - fase denominada pres&#237;ncope - y que no se justifica someter al paciente a tama&#241;o disconfort frente a la hipotensi&#243;n o bradicardia, que posibiliten la definici&#243;n de la respuesta vasovagal<sup>1,26,27</sup>. Los estudios m&#225;s recientes consideraron el criterio de positividad la inducci&#243;n de s&#237;ncope o de pres&#237;ncope, cuando est&#225; asociada a la bradicardia o hipotensi&#243;n arterial<sup>11,13,14,18,26,28</sup>. </p>
      <p>La clasificaci&#243;n modificada del VASIS (Vasovagal Syncope International Study) es la m&#225;s aceptada para definir los tipos de respuesta al test de inclinaci&#243;n: tipo 1 o mixta; tipo 2A o cardioinhibitoria sin asistolia; tipo 2B o cardioinhibitoria con asistolia; y tipo 3 o vasopresora (<xref ref-type="table" rid="es_a12tab02m-body2">Tabla 2</xref> y <xref ref-type="fig" rid="es_a12fig02m-body2">Figura 2</xref>)<sup>1</sup>. </p>
      <p content-type="asset">
        <table-wrap id="es_a12tab02m-body2">
          <graphic xlink:href="1678-4170-abc-96-03-0246-00006-gt02-es.jpg"/></table-wrap>
      </p>
      <p content-type="asset">
        <fig id="es_a12fig02m-body2">
          <graphic xlink:href="1678-4170-abc-96-03-0246-00006-gf02-es.jpg"/></fig>
      </p>
      <p>El tipo de respuesta al TI, entre tanto, no necesariamente define el <italic>gold standard</italic> hemodin&#225;mico del s&#237;ncope cl&#237;nico del paciente. El estudio ISSUE-2 mostr&#243; que 36% de los pacientes con respuesta mixta o vasodepresora al TI, presentaban asistolia durante el episodio espont&#225;neo grabado por el <italic>loop recorder</italic><sup>29</sup>. As&#237;, m&#225;s recientemente, se considera que la importancia de la respuesta al test de inclinaci&#243;n es especialmente la diferenciaci&#243;n entre s&#237;ncope reflejo y otras formas de intolerancia ortost&#225;tica<sup>5</sup>. </p>
      <p>
        <bold>Otros diagn&#243;sticos obtenidos por medio del test de inclinaci&#243;n</bold>
      </p>
      <p>Adem&#225;s de la respuesta vasovagal, el TI posibilita el diagn&#243;stico de otras formas de disautonom&#237;a e intolerancia ortost&#225;tica. La hipersensibilidad de los senos carot&#237;deos es confirmada si, durante el masaje, ocurre pausa ventricular mayor o igual a tres segundos o ca&#237;da de la presi&#243;n arterial sist&#243;lica mayor o igual a 50 mmHg<sup>1</sup>. La realizaci&#243;n del masaje bajo inclinaci&#243;n posibilita el diagn&#243;stico de mitad de los pacientes con la enfermedad que no ser&#237;an diagnosticados si el procedimiento fuese realizado apenas en posici&#243;n supina. En un estudio retrospectivo con 1.719 pacientes, el diagn&#243;stico de s&#237;ndrome de hipersensibilidad de los senos carot&#237;deos fue hecho en 226 casos durante la maniobra en posici&#243;n supina y en 217 casos solamente despu&#233;s de la repetici&#243;n de la maniobra bajo inclinaci&#243;n<sup>24</sup>. Adem&#225;s de eso, el monitoreo continuo de la PA durante el TI facilita la evaluaci&#243;n del componente vasodepresor, el que es importante para el diagn&#243;stico, ya que, en la mayor&#237;a de los casos, el s&#237;ncope es consecuencia tanto de la ca&#237;da de la FC como de la ca&#237;da de la PA - respuesta mixta. </p>
      <p>Otra disautonom&#237;a frecuente es el S&#237;ndrome de Taquicardia Postural Ortost&#225;tica o S&#237;ndrome Postural Ortost&#225;tico Taquicardizante, en que el paciente se queja principalmente de palpitaciones, mareos y pres&#237;ncope relacionados al ortostatismo. El TI es esencial para la confirmaci&#243;n del diagn&#243;stico, que es considerado positivo cuando ocurre aumento de la FC mayor o igual a 30 lpm despu&#233;s de la exposici&#243;n ortost&#225;tica en relaci&#243;n a la FC basal o manutenci&#243;n de FC superior a 120 lpm durante la inclinaci&#243;n<sup>30</sup>. En el otro extremo, est&#225; la incompetencia cronotr&#243;pica, caracterizada por la falla en el incremento de la frecuencia card&#237;aca durante la inclinaci&#243;n, o sea, incremento menor que 10% de la frecuencia card&#237;aca basal<sup>31</sup>. Ese diagn&#243;stico solo puede ser hecho en la ausencia del efecto de drogas cronotr&#243;picas negativas. </p>
      <p>El TI posibilita tambi&#233;n el diagn&#243;stico de otras formas de intolerancia ortost&#225;tica, como, por ejemplo, la respuesta disauton&#243;mica, caracterizada por ca&#237;da lenta y progresiva de la PA a niveles inferiores a 80 mmHg, sin ca&#237;da de la FC, asociada a s&#237;ntomas de hipotensi&#243;n arterial como sudores, mareos y oscurecimiento visual<sup>31</sup>. El paciente presenta ese cuadro a lo largo de, por lo menos, cinco minutos, sin ocurrencia de s&#237;ncope, y, en ese momento, el examen debe ser interrumpido. </p>
      <p>Las enfermedades primarias del sistema nervioso aut&#243;nomo (Insuficiencia Auton&#243;mica Pura, S&#237;ndrome de Shy-Drager y la Atrofia Multisist&#233;mica) o insuficiencias auton&#243;micas secundarias a enfermedades sist&#233;micas (S&#237;ndrome de Parkinson, <italic>Diabettes Mellitus</italic> y Amiloidose) tambi&#233;n pueden ser evaluadas por el TI<sup>32</sup>. Son caracterizadas por hipertensi&#243;n supina e hipotensi&#243;n ortost&#225;tica, que no se recuperan despu&#233;s de los primeros minutos de exposici&#243;n postural. Dependiendo de la intensidad de acometimiento auton&#243;mico, esta hipotensi&#243;n postural puede ser de mayor o menor magnitud y puede estar acompa&#241;ada de aumento insuficiente de la FC o no, caracterizando grados m&#225;s o menos avanzados de insuficiencia auton&#243;mica. </p>
      <p>
        <bold>Complicaciones</bold>
      </p>
      <p>El TI es un examen seguro si es realizado en las condiciones recomendadas encima y despu&#233;s de exclusi&#243;n de causas card&#237;acas para s&#237;ncope. En ese sentido, antes de la solicitud de ese examen, debe ser realizada una historia cl&#237;nica minuciosa acerca del episodio sincopal. Frente a la sospecha de causa card&#237;aca o neurol&#243;gica, se debe proceder a la investigaci&#243;n espec&#237;fica<sup>33</sup>. Leman et al. <sup>16</sup> reportaron la ocurrencia de fibrilaci&#243;n ventricular durante un TI con uso de isoproterenol en la dosis de 5 ug/kg/min en una paciente de 80 a&#241;os, con historia de infarto de miocardio antiguo y que estaba en investigaci&#243;n de s&#237;ncope, pero no hab&#237;a realizado ecocardiograma o test de isquemia mioc&#225;rdica previamente al TI. Despu&#233;s de desfibrilaci&#243;n con &#233;xito, la paciente fue sometida a coronariograf&#237;a que revel&#243; obstrucci&#243;n de 99% en la arteria circunfleja. </p>
      <p>En contrapartida, un estudio ingl&#233;s certific&#243; la seguridad de ese test. Fueron incluidos 1.969 a&#241;osos encima de 60 a&#241;os, siendo 44% encima de 75 a&#241;os, sometidos al TI por el protocolo pasivo o sensibilizado por el gliceril trinitato<sup>34</sup>. Apenas una paciente de 74 a&#241;os present&#243; fibrilaci&#243;n atrial a los 26 minutos de la inclinaci&#243;n pasiva, &#250;nico evento cardiovascular observado durante los ex&#225;menes, y no hubo eventos neurol&#243;gicos. Otro estudio realizado en Espa&#241;a no demostr&#243; ninguna complicaci&#243;n durante el examen de 1.219 individuos, desde j&#243;venes a a&#241;osos, en que se utiliz&#243; la metodolog&#237;a con apenas la fase pasiva o asociada a la sensibilizaci&#243;n con isoproterenol<sup>35</sup>. </p>
      <p>No es infrecuente la ocurrencia de asistolia prolongada como resultado del reflejo vasovagal inducido por el TI, sin embargo, en la mayor&#237;a de los casos, no es necesario iniciar maniobras de resucitaci&#243;n, siendo el retorno r&#225;pido a la posici&#243;n supina o a la posici&#243;n de Trendelemburg suficientes para la recuperaci&#243;n hemodin&#225;mica y de la conciencia. Ya fue relatada asistolia de 73 segundos, revertida con maniobras de resucitaci&#243;n y atropina, sin ninguna secuela despu&#233;s del examen<sup>36</sup>. Usualmente, las pausas son inferiores a 30 segundos, pero pausas mayores no son consideradas complicaciones, pero respuestas exacerbadas<sup>1</sup>. </p>
      <p>
        <bold>Uso cl&#237;nico y limitaciones</bold>
      </p>
      <p>Por la capacidad de reproducir los s&#237;ntomas del paciente en laboratorio, asociado a la comprobaci&#243;n de las alteraciones hemodin&#225;micas, el TI es utilizado para confirmar el diagn&#243;stico de la SVV hace m&#225;s de 20 a&#241;os. Directrices espec&#237;ficas recomiendan la utilizaci&#243;n para investigaci&#243;n diagn&#243;stica de s&#237;ncopes de origen inexplicada, pres&#237;ncopes, mareos, ca&#237;das y crisis convulsivas. </p>
      <p>En 2006, la Sociedad Americana de Cardiolog&#237;a present&#243; una Directriz que suger&#237;a que el TI presentaba poca contribuci&#243;n en la investigaci&#243;n diagn&#243;stica<sup>6</sup>. Las cr&#237;ticas reca&#237;an sobre la sensibilidad, especificidad, precisi&#243;n y reproductibilidad, y apenas cuatro referencias fueron presentadas para justificar la descalificaci&#243;n del test - mientras que la Directriz europea de s&#237;ncope no fue citada. Por otro lado, el Ad Hoc Syncope Consortium argument&#243; que tal documento fue incompleto, present&#243; apenas una visi&#243;n parcial del contexto de la enfermedad y pec&#243; de no aportar evidencias importantes y actualizadas, tales como la no citaci&#243;n de la Directriz europea de s&#237;ncope<sup>7</sup>. </p>
      <p>Otros autores tambi&#233;n cuestionan la validez del TI<sup>3,4</sup>. En relaci&#243;n a la sensibilidad y especificidad, algunos consideran que los resultados son muy diversos, dependiendo del m&#233;todo utilizado, en especial el grado de inclinaci&#243;n, de la duraci&#243;n de la fase pasiva, del uso o no de drogas sensibilizantes y del tipo de poblaci&#243;n estudiada. La variaci&#243;n de resultados es justificada exactamente por la evaluaci&#243;n de estudios con metodolog&#237;as muy distintas, una de las razones que llev&#243; a la estandarizaci&#243;n del examen en la directriz europea. Petkar y Fitzpatrick<sup>3 </sup>critican la baja sensibilidad del test apenas con fase pasiva y la ca&#237;da de la especificidad cuando se utilizan drogas sensibilizantes. Los autores ejemplifican la baja especificidad al describir un estudio que encontr&#243; 55% de falsos positivos en el test sensibilizado con isoproterenol<sup>3,37</sup>. Mientras tanto, en ese estudio, el TI fue realizado con inclinaci&#243;n de 80&#186;, lo que sabidamente reduce la especificidad, no siendo recomendado<sup>1</sup>. De la misma forma, analizando estudios m&#225;s recientes, se observa ca&#237;da importante de la especificidad cuando, en los protocolos sensibilizados, la fase pasiva tiene duraci&#243;n mayor o igual a 30 minutos. Protocolos con fases pasivas m&#225;s cortas, o aun ausentes, seguidos por la sensibilizaci&#243;n con nitrato o isoproterenol, se asocian a especificidades de 84 a 97%<sup>18,28,38</sup>, mientras que, en los estudios que utilizaron fases pasivas m&#225;s prolongadas, se observ&#243; reducci&#243;n en las especificidades (48 a 70%)<sup>9,11,15</sup>. As&#237;, la limitaci&#243;n de la duraci&#243;n total del examen parece garantizar buena especificidad. </p>
      <p>La sensibilidad apenas de la fase pasiva es bastante variable, pero la mayor&#237;a de los estudios encontr&#243; bajo &#237;ndice de positividad. Cuando esa fase tiene duraci&#243;n de 40 a 45 minutos, las sensibilidades encontradas fueron de 13%, 25%, 31% y 35%<sup>9-11,26</sup>. Apenas cuando la duraci&#243;n fue de 60 minutos es que la positividad aument&#243; a 75% con ca&#237;da de la especificidad para 89%. <sup>[12]</sup> Ya en los tests sensibilizados con nitrato, por ejemplo, la sensibilidad var&#237;a de 53 a 87%<sup>9,11,13-15,17,26</sup>. </p>
      <p>Considerando que la asociaci&#243;n de drogas aumenta significativamente la sensibilidad del TI y que la ca&#237;da de la especificidad puede ser aceptable, el protocolo combinado es el m&#225;s apropiado para uso cl&#237;nico en la investigaci&#243;n diagn&#243;stica del s&#237;ncope. </p>
      <p>
        <bold>Test de inclinaci&#243;n en la evaluaci&#243;n pron&#243;stica</bold>
      </p>
      <p>Algunos estudios ya fueron realizados con el objetivo de evaluar la capacidad del resultado del TI de predecir la evoluci&#243;n cl&#237;nica<sup>4</sup>. Hachul et al. <sup>39</sup> relataron que, despu&#233;s de instituci&#243;n del tratamiento para S&#237;ndrome Vasovagal, el TI con resultado negativo se asociaba a menor recurrencia de s&#237;ntomas en relaci&#243;n al resultado positivo (4.9 <italic>versus</italic> 52.4%, en 12 meses, p&lt;0,0001). Bastos et al. <sup>40 </sup>analizaron la capacidad del test en predecir la recurrencia de los s&#237;ntomas despu&#233;s de suspensi&#243;n de la medicaci&#243;n y observaron que 84% de los pacientes con TI positivo en esa situaci&#243;n presentaban recurrencia de los s&#237;ntomas con 12 meses de seguimiento. Adem&#225;s de eso, el tiempo medio para la primera recidiva fue significativamente menor en los pacientes con test positivo en relaci&#243;n a aquellos con test negativo. Por otro lado, algunos autores encontraron resultados distintos. Grim et al. <sup>41</sup> acompa&#241;aron 80 pacientes que realizaron TI, con al menos un episodio de s&#237;ncope previo, de los cuales apenas 14 pacientes tuvieron resultado positivo. Despu&#233;s de seguimiento medio de 23 meses, los autores concluyeron que el resultado del TI no fuera &#250;til en la predicci&#243;n de la evoluci&#243;n cl&#237;nica de los pacientes, pero la presencia de dos o m&#225;s episodios previos de s&#237;ncope. Sheldon et al. <sup>42</sup> demostraron que el riesgo de s&#237;ncope en dos a&#241;os era semejante entre pacientes con TI positivo y negativo. El m&#233;todo del test utilizado fue fase &#250;nica sensibilizada con isoproterenol, bajo inclinaci&#243;n a 80&#186; y con duraci&#243;n m&#225;xima de diez minutos, o sea, bastante diverso al que se utiliza en los d&#237;as de hoy. </p>
      <p>El estudio ISSUE tambi&#233;n es utilizado por algunos autores para justificar el bajo valor pron&#243;stico del TI<sup>3,4,43</sup>. Fueron incluidos 111 pacientes, de los cuales apenas 29 (26%) tuvieron TI positivo. En todos los pacientes, fue implantado un monitor de eventos electrocardiogr&#225;ficos (<italic>loop recorder</italic>), y fue observado que no hab&#237;a relaci&#243;n entre la positividad del TI y bradicardias documentadas en elmonitor de eventos. Mientras tanto, el diagn&#243;stico etiol&#243;gico del s&#237;ncope fue posible en apenas 20 (18%) de los pacientes (16 por asistolia mayor de tres segundos, tres por bradicardia severa y uno por taquicardia parox&#237;stica supraventricular), a pesar de la utilizaci&#243;n de un dispositivo implantable con seguimiento de hasta 15 meses. El peque&#241;o n&#250;mero de pacientes con resultado positivo en cada uno de los tests limita una conclusi&#243;n m&#225;s fidedigna de los datos. </p>
      <p>En estudio reciente, fueron controlados 276 pacientes con diagn&#243;stico cl&#237;nico de SVV por dos a&#241;os. EL TI, realizado seg&#250;n lo preconizado por la directriz europea, fue positivo en 37% de los pacientes. Los factores predictivos positivos de recurrencia del s&#237;ncope fueron n&#250;mero de eventos sincopales previos, sexo femenino y asma bronquial, excepto el TI<sup>44</sup>. Por lo tanto, hasta que surjan nuevos estudios, el resultado del TI no parece ser &#250;til en la evaluaci&#243;n pron&#243;stica del s&#237;ncope. </p>
      <p>
        <bold>Test de inclinaci&#243;n en la evaluaci&#243;n de la respuesta terap&#233;utica</bold>
      </p>
      <p>En relaci&#243;n a la repetici&#243;n del TI para evaluar la respuesta terap&#233;utica, dos variables deben ser discutidas. Una posible limitaci&#243;n de ese an&#225;lisis es la baja reproductibilidad del TI cuando el primer resultado es positivo, que var&#237;a de 31 a 92%<sup>1</sup>. La reproductibilidad del test negativo es mejor - 85 a 94%<sup>1</sup>. Otra variable es la propia indefinici&#243;n de cual medicaci&#243;n es realmente efectiva en el tratamiento de la enfermedad. Ya se trat&#243; de justificar como una posible causa de fracaso de la terapia con metoprolol, la selecci&#243;n de los pacientes con resultado positivo en el TI sensibilizado con isoproterenol<sup>4,45</sup>. Mientras tanto, un estudio randomizado y controlado con atenolol tampoco demostr&#243; reducci&#243;n de los s&#237;ntomas, a pesar de que los pacientes fueron seleccionados a partir de la caracterizaci&#243;n cl&#237;nica del s&#237;ndrome vasovagal, independientemente del resultado del TI<sup>46</sup>. El fracaso de la terapia con implante de marcapasos card&#237;aco tambi&#233;n ha sido atribuido a la selecci&#243;n de pacientes con bradicardia importante al TI<sup>3,4</sup>, con todo, otros estudios son necesarios para definir la eficacia de la estimulaci&#243;n artificial y as&#237; justificar los resultados negativos de los estudios previos por un sesgo de selecci&#243;n. </p>
      <p>
        <bold>&#191;Cuando es m&#225;s importante el test de inclinaci&#243;n?</bold>
      </p>
      <p>A pesar de que los pacientes con s&#237;ncope y ausencia de cardiopat&#237;a tienen un &#243;ptimo pron&#243;stico, muchos de ellos son atormentados por la ausencia de diagn&#243;stico definitivo, y la ansiedad subsecuente puede resultar en episodios m&#225;s frecuentes de s&#237;ncope vasovagal. Otro buen ejemplo de la importancia del TI est&#225; en la investigaci&#243;n de pacientes con historia de s&#237;ncope s&#250;bita y con evaluaci&#243;n cardiol&#243;gica negativa. El TI puede reproducir el s&#237;ncope sin pr&#243;dromos, que ocurre porque el paciente no percibe la ca&#237;da de la presi&#243;n arterial o de la frecuencia card&#237;aca, o porque el colapso hemodin&#225;mico se desarrolla de forma muy r&#225;pida. </p>
      <p>El SVV es responsable por 31 a 34% de los casos de s&#237;ncope en a&#241;osos<sup>47,48</sup>. En esa poblaci&#243;n, es especialmente importante la realizaci&#243;n del TI despu&#233;s de exclusi&#243;n de causa card&#237;aca, pues el diagn&#243;stico correcto y la instituci&#243;n del tratamiento adecuado pueden prevenir las ca&#237;das y las complicaciones decurrentes del s&#237;ncope, como fracturas y hematoma subdural. Adem&#225;s de eso, el TI aumenta la posibilidad de identificar hipersensibilidad de los senos carot&#237;deos, que est&#225; relacionada a hasta 20% de los s&#237;ncopes en los a&#241;osos<sup>49</sup>. El examen es tambi&#233;n muy &#250;til en la diferenciaci&#243;n con cuadros epil&#233;pticos, y la identificaci&#243;n del s&#237;ndrome disauton&#243;mica en esos pacientes evita las limitaciones sociales impuestas por el diagn&#243;stico de epilepsia y los efectos colaterales decurrentes de la medicaci&#243;n anticonvulsivante<sup>50</sup>. </p>
      <p>Aun, es posible caracterizar el s&#237;ncope psicog&#233;nico durante el TI, cuando el paciente simula el episodio sincopal sin que se observe ninguna alteraci&#243;n hemodin&#225;mica asociada<sup>51</sup>. Otros diagn&#243;sticos asociados al s&#237;ncope, como la intolerancia ortost&#225;tica y el S&#237;ndrome de Taquicardia Ortost&#225;tica Postural, tambi&#233;n pueden ser revelados o confirmados por el TI. </p>
      <p>
        <bold>Perspectivas</bold>
      </p>
      <p>En la tentativa de mejorar la especificidad del examen y la tolerancia de los pacientes, han sido testeados protocolos m&#225;s cortos del TI. En ese sentido, los m&#233;todos en estudio han evaluado la reducci&#243;n del tiempo o la exclusi&#243;n de la fase pasiva, y los resultados hasta el momento son conflictivos. </p>
      <p>En pacientes con s&#237;ncope inexplicado, Bartoletti et al. <sup>38</sup> compararon los resultados de la inclinaci&#243;n pasiva por 45 minutos <italic>versus</italic> inclinaci&#243;n con nitrato precedida por fase pasiva de apenas cinco minutos. En ese estudio, la tasa de positividad fue significativamente superior con el m&#233;todo cl&#225;sico, de 45 minutos (51% <italic>versus</italic> 35%, p=0,04), sugiriendo que fuese necesaria fase pasiva mayor antes de la administraci&#243;n del nitrato. Entre tanto, esa conclusi&#243;n diverge de otros estudios. Aerts et al. <sup>52</sup> evaluaron el tratamiento con nitrato precedido por tres protocolos de inclinaci&#243;n pasiva: 45 minutos, 30 minutos y sin fase pasiva. Los autores encontraron sensibilidad de 87%, 77% y 76%, respectivamente, y especificidad casi inalterada de 83%, 83% y 82%, respectivamente. Hubo peque&#241;a diferencia en la precisi&#243;n, aunque sin significaci&#243;n estad&#237;stica, de 78%, 80% y 71%, respectivamente. Adem&#225;s de eso, en ese estudio, fue encontrada sensibilidad mayor que en el estudio de Bartoletti et al. <sup>38</sup>, consecuencia probable de la selecci&#243;n de pacientes con historia cl&#237;nica t&#237;pica de s&#237;ncope vasovagal. </p>
      <p>M&#225;s recientemente, Aerts y Dendale<sup>28</sup> analizaron la precisi&#243;n del TI sin fase pasiva. Treinta y ocho pacientes y treinta individuos sanos fueron sometidos al TI despu&#233;s de administraci&#243;n de 400 ug de nitroglicerina sublingual, por un per&#237;odo m&#225;ximo de 30 minutos. Se observaron sensibilidad de 82%, especificidad de 84% y precisi&#243;n de 83%. Los autores relatan aun que, analizando los resultados obtenidos a los 15 minutos, no hubo ca&#237;da significativa de la sensibilidad, sugiriendo que el examen pudiese tener duraci&#243;n m&#225;s corta. Adem&#225;s de eso, en comparaci&#243;n con estudios anteriores, fue encontrada elevada sensibilidad, lo que los autores atribuyen a la selecci&#243;n de pacientes con fuerte sospecha cl&#237;nica de s&#237;ncope vasovagal. </p>
      <p>El &#237;ndice de falsos negativos en el TI durante investigaci&#243;n de s&#237;ncope vasovagal aun es significativo - llegando hasta 30%, cuando se utiliza el nitrato<sup>14</sup>. As&#237;, nuevas drogas sensibilizantes deben ser probadas para reducir ese &#237;ndice. Ex&#225;menes con resultados falsos positivos son menos frecuentes, pero los estudios muestran que en media 15% de los pacientes sin historia previa de s&#237;ncope tienen resultado positivo. El esclarecimiento de los mecanismos envueltos y de los l&#237;mites entre la respuesta fisiol&#243;gica y la respuesta patol&#243;gica ciertamente facilitar&#225; la interpretaci&#243;n del examen. </p>
      <p>Otros estudios son necesarios tambi&#233;n para definir la utilidad del TI en la evaluaci&#243;n pron&#243;stica y en la programaci&#243;n terap&#233;utica. Ya el uso en el control de la respuesta al tratamiento del SVV depende primeramente de la comprobaci&#243;n de la eficacia del tratamiento. Estudios randomizados y controlados mostraron que algunas medicaciones hasta hace poco tiempo bastante utilizadas y el uso de dispositivos implantables no son eficaces en la reducci&#243;n de los eventos sincopales<sup>45,46,53</sup>. </p>
      <p>
        <bold>Conclusiones</bold>
      </p>
      <p>El TI es un examen &#250;til en la investigaci&#243;n del s&#237;ncope inexplicado. La utilizaci&#243;n indiscriminada y sin criterios metodol&#243;gicos bien demostrados puede comprometer su credibilidad e importancia. </p>
      <p>El examen tiene papel relevante en el diagn&#243;stico diferencial y ha sido fundamental en la comprensi&#243;n de las alteraciones hemodin&#225;micas relacionadas a las disautonom&#237;as. Tal vez, con la evoluci&#243;n del conocimiento sobre la fisiopatolog&#237;a y el tratamiento de esas enfermedades, los resultados del TI puedan ser utilizados tambi&#233;n en la orientaci&#243;n terap&#233;utica. </p>
      <p>La metodolog&#237;a del TI viene siendo mejorada a lo largo del tiempo. As&#237;, los protocolos propuestos deben ser evaluados considerando los posibles falsos positivos y falsos negativos, y el objetivo de los futuros estudios debe ser el desarrollo de m&#233;todos que presenten mejor precisi&#243;n sin p&#233;rdida de la especificidad. </p>
      <p>Concluyendo, el TI es un examen no invasivo importante en la evaluaci&#243;n diagn&#243;stica del s&#237;ncope inexplicado, pero presenta limitaciones y algunas veces no es capaz de definir el diagn&#243;stico. Mientras tanto, esas imperfecciones no justifican el abandono del test, pero la b&#250;squeda por el mejoramiento de la t&#233;cnica. En la pr&#225;ctica cl&#237;nica, el TI tiene su lugar reconocido, pero es fundamental que la indicaci&#243;n sea criteriosa y que los protocolos obedezcan a los propuestos en las normatizaciones internacionales, para permitir la interpretaci&#243;n correcta de los resultados. </p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes. </p>
      <p>
        <bold>Fuentes de Financiamiento</bold>
      </p>
      <p>El presente estudio no tuvo fuentes de financiamiento externas. </p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo es parte de disertaci&#243;n de Maestr&#237;a de Paula Gon&#231;alves Macedo por la Universidad de Brasilia. </p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Tilt test: from the necessary to the indispensable</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>The head-up tilt test (HUTT) is widely used for investigation of syncope and presyncope, since it allows diagnosing different types of dysautonomia. The main cause of syncope is the vasovagal syndrome, the most common diagnosis among patients with HUTT indication. The test has been used for nearly 20 years, but many doctors are unaware of the methodology. After the cardiac causes of syncope are ruled out, the appropriate indication of the test and instructions to patients are important to ensure that the test will be carried out in a safe and relaxed manner. There are controversies in the literature over the diagnostic capacity and reliability of results. Studies with various protocols may explain the variability of results. This review describes the guidelines-recommended methodology and indications, complications, limitations and perspectives of this test.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Tilt test</kwd>
        <kwd>syncope</kwd>
        <kwd>vasovagal syndrome</kwd>
        <kwd>guidelines</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p><undefined id="tx-body3"/>Tilt test - from the necessary to the indispensable</p>
      <p>
        <bold>Paula Gon&#231;alves Macedo<sup>II,III</sup>; Luiz R. Leite<sup>II</sup>; Leopoldo Santos-Neto<sup>III</sup>; Denise Hachul<sup>I</sup></bold>
      </p>
      <p><sup>I</sup>Faculdade de Medicina da Universidade de S&#227;o Paulo, S&#227;o Paulo, SP</p>
      <p><sup>II</sup>Centro de Fibrila&#231;&#227;o Atrial do Distrito Federal - Hospital de Base</p>
      <p><sup>III</sup>Universidade de Bras&#237;lia, DF - Brazil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p>The head-up tilt test (HUTT) is widely used for investigation of syncope and presyncope, since it allows diagnosing different types of dysautonomia. The main cause of syncope is the vasovagal syndrome, the most common diagnosis among patients with HUTT indication. The test has been used for nearly 20 years, but many doctors are unaware of the methodology. After the cardiac causes of syncope are ruled out, the appropriate indication of the test and instructions to patients are important to ensure that the test will be carried out in a safe and relaxed manner. There are controversies in the literature over the diagnostic capacity and reliability of results. Studies with various protocols may explain the variability of results. This review describes the guidelines-recommended methodology and indications, complications, limitations and perspectives of this test.</p>
      <p><bold>Keywords:</bold> Tilt test; syncope; vasovagal syndrome; guidelines.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>The head-up tilt test (HUTT) is a widely used method for investigation of syncope, presyncope, dizziness, palpitations related to orthostatism and dysautonomia symptoms<sup>1</sup>. However, the main indication has been to investigate the vasovagal syndrome (VVS). </p>
      <p>In 1986, Kenny et al<sup>2</sup> reported, for the first time, the usefulness of HUTT in the investigation of patients with syncope of probable vasovagal origin. They noted that the exposure to a 60&#176; tilt for 60 minutes triggered the vasovagal reflex in 66% of patients with syncope of unexplained origin. Since then, protocols of shorter duration or drug-potenciated protocols have been used, so as to increase sensitivity and shorten the execution time of the test. </p>
      <p>Lately, the test has been criticized due to a great variation in sensitivity and specificity rates in different studies. Furthermore, the result of the HUTT has well-defined therapeutic implications and the reproducibility is limited<sup>3,4</sup>.</p>
      <p>The European Guidelines on Diagnosis and Management of Syncope, updated in 2009, describe the recommendations of the methodology and the indications of the test and types of response that are expected<sup>5</sup>. In this paper, we discuss the current indications, protocols, limitations and perspectives of this test.</p>
      <p>
        <bold>Indications of the tilt test</bold>
      </p>
      <p>The 2006 American Heart Association Scientific Statement on The Evaluation of Syncope does not recommend HUTT for evaluation of syncope, but such document has attracted widespread criticism, which will be commented on below<sup>6,7</sup>. In clinical practice, the indications described by the European Guidelines of Syncope are used<sup>5</sup>. These guidelines state that the HUTT shall be used for diagnostic purposes in the situations below.</p>
      <p>
        <bold>Class I recommendation</bold>
      </p>
      <p>In young patients, without obvious or suspected heart disease, with recurrent syncope of unexplained origin, in which the history is not typical enough for the diagnosis of neurally mediated syncope.</p>
      <p>In cases of a single episode of unexplained syncope, which occurred in situation where there is high risk of physical injury or with occupational implications; or in cases of recurrent syncope in the absence of heart disease, or yet, if in patients with heart disease, the cardiac causes of syncope are ruled out.</p>
      <p>In cases where the demonstration of susceptibility to neurally mediated syncope is clinically relevant.</p>
      <p>
        <bold>Class II recommendation</bold>
      </p>
      <p>When understanding the pattern of hemodynamic response during syncope may alter the treatment planning.</p>
      <p>In the differentiation between convulsive syncope and epilepsy.</p>
      <p>In diagnosis to differentiate between reflex syncope and orthostatic hypotension.</p>
      <p>For the evaluation of patients that have had unexplained recurrent falls.</p>
      <p>When dealing with patients with presyncope or recurrent dizziness.</p>
      <p>In the evaluation of patients with recurrent syncope and psychiatric illnesses.</p>
      <p>The European guidelines state that, in cases in which the test is recommended and in the absence of an associated heart disease, the positive result with reproduction of the spontaneous syncope is sufficient for defining the diagnosis of neurally mediated syncope.</p>
      <p>The use of HUTT for controlling treatments or for monitoring the VVS in the long term has not been recommended. Even though the European guidelines on syncope do not recommend the HUTT for patients that have a typical clinical history of VVS, the tilt test is valuable in identifying the type of VVS (cardioinhibitory, vasodepressor or mixed). Some authors recommend different treatment options depending on the type of vasovagal syncope, so in this case, HUTT would serve as therapeutic guidance<sup>5,8</sup>. Pachon et al<sup>8</sup> recently published a new therapeutic alternative for patients with neurocardiogenic syncope, which would be more suitable for patients with cardioinhibitory VVS.</p>
      <p>
        <bold>Protocols</bold>
      </p>
      <p>In the descriptions of previous protocols, the terms "sensitivity" and "positivity" get mixed up due to the absence of a gold standard test for diagnosing VVS. When the clinical diagnosis is considered to be the gold standard, the term "HUTT sensitivity" has been used, because the patient with the disease was selected according to the clinical history. When the test is carried out in patients with unexplained syncope, the term "positivity" is generally applied. However, in this review, the term "sensitivity" was standardized for both situations, in order to simplify the description of the studies, but it is understood that in many cases, the term represents only the positivity of the test. The use of clinical diagnosis as the gold standard has been criticized because of the subjectivity inherent in medical judgment. However, to date, no other method has proved to be more accurate.</p>
      <p>Initially, the authors recommended only the orthostatic tilt for prolonged periods, without the use of drugs, which is called the extended passive protocol. In the analysis of five studies that evaluated the result of exposure to passive orthostasis, lasting at least 40 minutes, the sensitivity rates noted were 13%, 25%, 31%, 35% and 75% (median of 31%)<sup>9-12</sup>. In contrast to the low sensitivity, the specificity was 100%, 100%, 95%, 92% and 89%, respectively (mean of 95%).</p>
      <p>In an attempt to increase the diagnostic accuracy of HUTT, the administration of various sensitizing drugs was tested after a negative passive phase. </p>
      <p>Currently, isoproterenol and nitrate are the drugs most commonly used for this purpose. In the several studies conducted, the sensitivity of the test with nitrate ranged between 57.5% and 87%, and the specificity between 70% and 100%, while the test with isoproterenol showed variations between 42% and 69% and between 70 and 90%, respectively<sup>9,11,13-15</sup>. Isoproterenol is being abandoned due to the lower sensitivity, inconvenience of intravenous access and side effects, especially in patients with ischemic heart disease<sup>16 </sup>(<xref ref-type="table" rid="tab01-body3">Table 1</xref>).</p>
      <table-wrap id="tab01-body3">
        <graphic xlink:href="1678-4170-abc-96-03-0246-00006-gt01-en.jpg"/></table-wrap>
      <p>Initially, nitrate was used in the form of intravenous nitroglycerin, with sensitivity of 53% and specificity of 92%, considering only the sensitized phase<sup>17</sup>. In a subsequent study, the same researchers evaluated the effect of sublingual nitroglycerin<sup>10</sup>. Initially, patients lay on a table that was tilted up to an angle of 60&#176; for 45 minutes (passive tilt), which resulted in low sensitivity (25%) and high specificity (100%). After administration of 300 mg of sublingual nitroglycerin, a positive response was observed in more than 26% of the patients and in 6% of the control group, resulting in a specificity of 94%. Similar data were presented by other authors in subsequent years<sup>9,15,18</sup> (<xref ref-type="table" rid="tab01-body3">Table 1</xref>). </p>
      <p>The European guidelines on syncope, published in 2004, reported an analysis of studies that used 20 or 45 minutes of passive phase followed by sensitization with nitrate. The conclusion reached was that the sensitivity of tests of shorter or longer duration is similar (69% versus 62%), without any decrease in specificity (94% for the protocols with 20 minutes of passive phase)<sup>1</sup>. Since then, it is recommended that the HUTT should consist of 20 minutes of passive phase and 20 minutes of sensitized phase (nitroglycerin or isoproterenol). Thus, the classical protocol (without the use of sensitizing drugs) has been replaced by the protocol that combines the passive phase followed by the sensitized phase.</p>
      <p>In Brazil, sublingual nitroglycerin has not been traded since 2002, so the vasodilator used is isosorbide dinitrate, at a dose of 1.25 mg (1/4 of the sublingual administration pill), as recommended by the Brazilian Guidelines for Evaluation and Treatment of Patients with Cardiac Arrhythmias, published in 2002<sup>19</sup>. In three studies that evaluated the use of this drug during the HUTT, the sensitivity ranged from 57 to 87%, and specificity from 70 to 100%<sup>9,14,15</sup>. The dose of 1.25 mg was evaluated in only one of these studies and it was the one related to the highest specificity (100%)<sup>15</sup>.</p>
      <p>The sensitization of the test with the use of nitrate reproduces the same types of vasovagal responses as the passive tilt: cardioinhibitory, vasodepressor and mixed<sup>20</sup>. However, the mechanism by which nitrate induces vasovagal syncope is still not understood, and the most studied hypotheses have been: 1. vasodilatation, 2. activation of the sympathetic nervous system, 3. direct action in the central nervous system (CNS), and 4. action in the central nervous system (CNS) via neurohormones<sup>20-22</sup>.</p>
      <p>
        <bold>Recommended methodology</bold>
      </p>
      <p>HUTT must be conducted in a quiet environment, with dimmed lighting and pleasant temperature. The monitoring is carried out by doctors and nursing technicians, trained for the test, and the presence of relatives is not recommended. The room must be equipped with cardiac resuscitation materials, although the use of such materials is rarely necessary<sup>19</sup>. Patients must fast for at least four hours for liquids and six hours for solids and they must lie down for at least ten minutes, before the tilting<sup>19</sup>. Venipuncture should be avoided in this phase, but if necessary, the resting time before the test should be increased to at least 20 minutes<sup>1</sup>. The test table has a footrest and safety straps and it can be tilted up to 60 or 70 degrees (<xref ref-type="fig" rid="fig01-body3">Figure 1</xref>). Angles that are above and below the default configuration show lower specificity and lower sensitivity of HUTT, respectively<sup>1,23</sup>. Throughout the examination, electrocardiogram and blood pressure (BP) readings are used to monitor the patient. Ideally, BP should be monitored in a continuous and non-invasive way. If the BP is intermittently measured, the interval between measurements should be as small as possible, especially in the phase that is close to the positive result of the test. In patients aged over 40 and with a clinical history of syncope, the carotid sinus massage is also recommended, because during tilting, the sensitivity of this technique is higher, and it is also possible to evaluate the vasodepressor component<sup>24</sup>. The test can be carried out at any time of day, but when the goal is to study the reproducibility of results, it is important to repeat the test at the same time it is was previously carried out<sup>25</sup>.</p>
      <fig id="fig01-body3">
        <graphic xlink:href="1678-4170-abc-96-03-0246-00006-gf01-en.jpg"/></fig>
      <p>
        <bold>Types of response to tilt testing</bold>
      </p>
      <p>The Brazilian Guidelines for Evaluation and Treatment of Patients with Cardiac Arrhythmias considers the HUTT positivity criterion when there is reproduction of the spontaneous symptoms associated with the hemodynamic collapse<sup>19</sup>. There is controversy surrounding the interruption of the test before the occurrence of syncope. Many authors consider that it is enough to stop the HUTT when the doctor believes that the loss of consciousness is imminent &#150; phase called presyncope -, and there is no reason to subject the patient to the huge discomfort resulting from hypotension or bradycardia, which will allow defining the vasovagal response<sup>1,26,27</sup>. More recent studies have considered that the positivity criterion is the induction of syncope or presyncope, when associated with bradycardia or hypotension<sup>11,13,14,18,26,28</sup>.</p>
      <p>A modified classification of VASIS (Vasovagal Syncope International Study) is the most accepted one to define the types of response to tilt testing: type 1 or mixed; type 2A or cardioinhibitory without asystole; type 2B or cardioinhibitory with asystole; and type 3 or vasodepressor (<xref ref-type="table" rid="tab02-body3">Table 2</xref> and <xref ref-type="fig" rid="fig02-body3">Figure 2</xref>)<sup>1</sup>.</p>
      <table-wrap id="tab02-body3">
        <graphic xlink:href="1678-4170-abc-96-03-0246-00006-gt02-en.jpg"/></table-wrap>
      <fig id="fig02-body3">
        <graphic xlink:href="1678-4170-abc-96-03-0246-00006-gf02-en.jpg"/></fig>
      <p>However, the type of response to HUTT does not necessarily define the hemodynamic pattern of the patient&#146;s clinical syncope. The ISSUE-2 study showed that 36% of patients with mixed or vasodepressor response to HUTT had asystole during a spontaneous episode recorded by the loop recorder<sup>29</sup>. Thus, more recently, it has been considered that the most important aspect of the response to tilt testing is the differentiation between reflex syncope and other forms of orthostatic intolerance<sup>5</sup>.</p>
      <p>
        <bold>Other diagnoses obtained by means of the tilt test</bold>
      </p>
      <p>Besides the vasovagal response, HUTT allows diagnosing other forms of dysautonomia and orthostatic intolerance. The carotid sinus hypersensitivity is confirmed if, during the massage, there is a ventricular pause that exceeds or is equal to three seconds or if there a drop in systolic blood pressure that is greater than or equal to 50 mmHg<sup>1</sup>. The massage during tilt allows diagnosing half of the patients with the disease that would not be diagnosed if the procedure was performed only in a supine position. In a retrospective study with 1,719 patients, the diagnosis of carotid sinus hypersensitivity was made in 226 cases during the procedure in the supine position and in 217 cases only after repeating the procedure at a tilted position<sup>24</sup>. In addition, the continuous monitoring of BP during the HUTT makes it easier to evaluate the vasodepressor component, which is important for the diagnosis because, in most cases, syncope results both from the drop in HR and the decrease in BP - mixed response. </p>
      <p>Another frequent dysautonomia is the Postural Orthostatic Tachycardia Syndrome or Postural Tachycardia Syndrome, in which the patient complains mainly of palpitations, dizziness and presyncope related to orthostatism. HUTT is essential to confirm the diagnosis, which is considered positive when there is an increase in HR that is greater than or equal to 30 bpm, after orthostatic exposure in relation to basal HR or maintenance of HR above 120 bpm during the tilt<sup>30</sup>. On the other hand, there is the chronotropic incompetence, which is characterized by the failure to increase the heart rate during the tilt, i.e., an increase of less than 10% of the baseline heart rate<sup>31</sup>. This diagnosis can only be made when there are no effects of negative chronotropic drugs.</p>
      <p>HUTT also allows diagnosing other forms of orthostatic intolerance, such as the dysautonomic response, characterized by slow and progressive drop in BP to below 80 mmHg, without any drop in HR, associated with symptoms of hypotension such as sudoresis, dizziness and blurred vision<sup>31</sup>. The patient has these symptoms for at least five minutes without the occurrence of syncope, and at such moment, the examination shall be discontinued.</p>
      <p>The primary diseases of the autonomic nervous system (Pure Autonomic Failure, Shy-Drager Syndrome and Multiple System Atrophy) or secondary autonomic failures to systemic diseases (Parkinson&#146;s Syndrome, Diabetes mellitus and Amyloidosis) can also be evaluated by HUTT<sup>32</sup>. They are characterized by supine hypertension and orthostatic hypotension, which do not recover after the first few minutes of postural exposure. Depending on the intensity of the autonomic impairment, this postural hypotension may be of greater or lesser magnitude and it may be accompanied by insufficient increase in HR or not, thereby indicating more or less advanced degrees of autonomic failure. </p>
      <p>
        <bold>Complications</bold>
      </p>
      <p>HUTT is a safe examination if it is carried out under the conditions recommended above and if the cardiac causes for syncope are ruled out. In this sense, before requesting this test, it is important to survey the clinical history of the syncope episode. If there is the suspicion of cardiac or neurological cause, the specific investigation must be conducted<sup>33</sup>. Leman et al<sup>16</sup>. reported the occurrence of ventricular fibrillation during a tilt test with the use of isoproterenol at a dose of 5 ug/kg/min, in an 80-year-old patient, with history of previous myocardial infarction and who was being tested for syncope, but who had not undergone an echocardiogram or had not been tested for myocardial ischemia prior to the HUTT. After successful defibrillation, the patient underwent coronary angiography, which revealed 99% obstruction of the circumflex artery.</p>
      <p>In contrast, an English study attested to the safety of this test. The study included 1,969 elderly people aged over 60, 44% of whom were over 75 years old. The tilt test consisted of a passive phase followed by a sensitized phase with using the passive protocol or the protocol sensitized by glyceryl trinitrate<sup>34</sup>. Only a 74-year-old patient had atrial fibrillation at the 26<sup>th</sup> minute of the passive tilt, which was the only cardiovascular event observed during the tests, and there was no neurological event. Another study conducted in Spain showed no complications during the examination of 1,219 individuals, including young and old people, in which the methodology with only the passive phase was used or the passive phase together with isoproterenol sensitization<sup>35</sup>.</p>
      <p>The occurrence of prolonged asystole, as a result of vasovagal reflex induced by HUTT, is not rare, but in most cases, it is not necessary to initiate resuscitation, because the quick return to the supine position or Trendelenburg position is enough for regaining of consciousness. There have been reports of asystole of 73 seconds, which was reversed with resuscitation and atropine, without any sequelae after the examination<sup>36</sup>. The pauses usually last less than 30 seconds, but longer pauses are not considered major complications. Such pauses are considered exacerbated responses<sup>1</sup>.</p>
      <p>
        <bold>Clinical use and limitations</bold>
      </p>
      <p>Due to its capacity to reproduce the patient&#146;s symptoms in a laboratory, together with the corroboration of hemodynamic changes, the tilt test has been used to confirm the diagnosis of VVS for over 20 years. Specific guidelines recommend the use for diagnosis of syncope of unexplained origin, presyncope, dizziness, falls and seizures.</p>
      <p>In 2006, the American Heart Association Scientific Statement suggested that HUTT contributed little to the diagnostic investigation<sup>6</sup>. The criticism was about the sensitivity, specificity, accuracy and reproducibility, and only four references were provided to justify the disqualification of the test - while the European Guidelines on syncope were not cited. On the other hand, the Ad Hoc Syncope Consortium argued that such document was incomplete, showed only a partial view of the disease context and failed to mention current and important evidence, such as the European Guidelines on syncope<sup>7</sup>.</p>
      <p>Other authors have also questioned the validity of HUTT<sup>3,4</sup>. With regard to sensitivity and specificity, some people consider that the results are very different, depending on the method used, specially the degree of tilt, duration of the passive phase, the use or non-use of sensitizing drugs and the type of population studied. The variation in results is justified exactly by the evaluation of studies that use very different methodologies, which is one of the reasons that led to the standardization of the test in the European Guidelines. Petkar e Fitzpatrick<sup>3 </sup>criticize the low sensitivity of the test with only the passive phase and the decrease in specificity when sensitizing drugs are used. The authors illustrate the low specificity by mentioning a study that found 55% false positives in a test sensitized with isoproterenol<sup>3,37</sup>. However, in this study, the tilt test was carried out with a tilt of 80 degrees, which is known to reduce the specificity and it is not recommended<sup>1</sup>. Likewise, when one analyzes more recent studies, it is possible to notice a significant decrease in specificity when, in sensitized protocols, the duration of the passive phase is equal to or more than 30 minutes. Protocols with shorter passive phases, or even without a passive phase, followed by sensitization with nitrate or isoproterenol, are linked with specificities that range from 84 to 97%<sup>18,28,38</sup>, whereas, in studies that used a more prolonged passive phase, there was a decrease in specificities (48 to 70%)<sup>9,11,15</sup>. Therefore, limiting the total duration of the examination seems to guarantee good specificity.</p>
      <p>The sensitivity of the passive phase alone is highly variable, but most studies have found low rates of positivity. When this phase lasted between 40 and 45 minutes, the sensitivities found were 13%, 25%, 31% and 35%<sup>9-11,26</sup>. It was only when the duration was 60 minutes that the positivity increased to 75% yet the specificity decreased to 89%<sup>12</sup> . As for the tests sensitized with nitrate, for example, the sensitivity varies between 53 and 87%<sup>9,11,13-15,17,26</sup>.</p>
      <p>Considering that the combination with drugs significantly increases the sensitivity of HUTT and that the decrease in specificity may be acceptable, the combined protocol is most suitable for clinical use in the diagnostic investigation of syncope.</p>
      <p>
        <bold>Tilt test in the prognostic evaluation</bold>
      </p>
      <p>Some studies have been conducted to evaluate the ability of the HUTT result to predict the clinical evolution<sup>4</sup>. Hachul et al<sup>39</sup> reported that, after the institution of the treatment for Vasovagal Syndrome, the HUTT with negative result was associated with the lower recurrence of symptoms in relation to the positive result (4.9 <italic>versus</italic> 52.4%, in 12 months, p&lt;0.0001). Bastos et al<sup>40</sup> analyzed the capacity of the test to predict the recurrence of symptoms after discontinuation of medication and they found that 84% of patients with positive HUTT, under this condition, developed the symptoms again after being monitored for 12 months. Moreover, the average time for the first relapse was significantly shorter in patients with positive test compared to those with a negative test. However, some authors found different results. Grim et al<sup>41</sup> monitored 80 patients with whom the HUTT test had been carried out, with at least one prior episode of syncope. Only 14 patients of such patients had a positive result. After monitoring the patients for 23 months, on average, the authors concluded that the result of the HUTT was not useful to predict the clinical course of patients, but the presence of two or more previous episodes of syncope was. Sheldon et al<sup>42</sup> demonstrated that the risk of syncope in two years was similar among patients with positive and negative HUTT. The test method used was a single phase sensitized with isoproterenol, at a tilt of 80&#186; and maximum duration of ten minutes, which is quite different from what is used today.</p>
      <p>The ISSUE study is also used by some authors to justify the low prognostic value of HUTT<sup>3,4,43</sup>. One hundred and eleven patients were included, and only 29 of them (26%) had a positive HUTT. A device to monitor electrocardiographic events (loop recorder) was implanted in all patients, and it was possible to notice that there was a relationship between the HUTT positivity and the bradycardias recorded in the event monitoring device. However, the etiologic diagnosis of syncope was possible in only 20 (18%) patients (16 due to asystole lasting longer than three seconds, three due to severe bradycardia and one due to paroxysmal supraventricular tachycardia), despite the use of an implantable device that could monitor events for up to 15 months. The small number of patients with positive outcome in each one of the tests makes it difficult to reach a more reliable conclusion on the data. </p>
      <p>In a recent study, 276 patients diagnosed with VVS were monitored for two years. The HUTT, which was carried out as recommended by European guidelines, was positive in 37% of patients. The positive predictive factors for syncope recurrence were the number of prior syncope events, female gender and bronchial asthma, but not the HUTT<sup>44</sup>. Therefore, before the emergence of new studies, the result of HUTT does not seem to be useful in the prognostic evaluation of syncope.</p>
      <p>
        <bold>Tilt test in evaluation of the therapeutic response</bold>
      </p>
      <p>With respect to the repetition of HUTT to assess the therapeutic response, two variables should be discussed. A possible limitation of this analysis is the poor reproducibility of HUTT when the first result is positive, which ranges from 31 to 92%<sup>1</sup>. On the other hand, the reproducibility of the negative test is better - 85 to 94%<sup>1</sup> . Another variable is the very failure to define which medication is really effective in treating the disease. There have been attempts to explain the failure of the therapy with metoprolol, by attributing the cause of such failure to the selection of patients with positive result in the HUTT sensitized with isoproterenol<sup>4,45</sup>. However, a randomized and controlled study with atenolol also showed no reduction in symptoms, although the selection of patients was based on the clinical characterization of vasovagal syndrome, regardless of the outcome of HUTT<sup>46</sup>. The failure of the therapy with the use of a pacemaker has also been attributed to the selection of patients with bradycardia during the HUTT<sup>3,4</sup>. However, further studies are needed to define the efficacy of artificial cardiac stimulation and, this way, justify the negative results of previous studies by a selection bias.</p>
      <p>
        <bold>When is the tilt test most important?</bold>
      </p>
      <p>Even though the prognosis of patients with syncope and without heart disease is excellent, many of them are tormented by the absence of a definitive diagnosis, and the subsequent anxiety may result in more frequent episodes of vasovagal syncope. Another good example of the importance of the tilt test is the investigation of patients with a history of sudden syncope and with negative cardiac evaluation. The HUTT can reproduce the syncope without prodromes, which occur either because the patient does not notice the drop in blood pressure or heart rate, or because the hemodynamic collapse develops very quickly.</p>
      <p>The VVS is responsible for 31 to 34% of the syncope cases in the elderly<sup>47,48</sup> In this population, it is especially important to perform the HUTT after the cardiac causes are ruled out, because the correct diagnosis and appropriate treatment can prevent falls and complications resulting from the syncope, such as fractures and subdural hematoma. In addition, the HUTT increases the chance of identifying carotid sinus hypersensitivity, which is linked with up to 20% of syncopes in the elderly<sup>49</sup>. The test is also very useful in the differentiation with epileptic symptoms, and the identification of the dysautonomia syndrome in these patients avoids the social limitations imposed by the diagnosis of epilepsy and side-effects resulting from the anticonvulsant medication<sup>50</sup>.</p>
      <p>In addition, it is possible to characterize the psychogenic syncope during the HUTT, when the patient simulates the syncope episode, without any sign of related hemodynamic change<sup>51</sup>. Other diagnoses associated with syncope, such as orthostatic intolerance and Postural Orthostatic Tachycardia Syndrome, also may be revealed or confirmed by HUTT.</p>
      <p>
        <bold>Perspectives</bold>
      </p>
      <p>In an attempt to improve the specificity of the test and patients, shorter HUTT protocols have been tested. In this sense, the methods under study have evaluated the reduction in time or the exclusion of the passive phase, and the results so far are conflicting. </p>
      <p>In patients with unexplained syncope, Bartoletti et al<sup>38</sup> compared the results of passive tilt for 45 minutes <italic>versus</italic> tilt with nitrate preceded by a passive phase lasting only five minutes. In this study, the positivity rate was significantly higher with the classic 45-minute-long method (51% versus 35%, p=0.04), suggesting that a longer passive phase would be necessary before administering the nitrate. However, this conclusion differs from other studies. Aerts et al<sup>52</sup> assessed the HUTT with nitrate preceded by three passive tilt protocols: 45 minutes, 30 minutes and without passive phase. The authors found sensitivities of 87%, 77% and 76%, respectively, and almost unchanged specificity of 83%, 83% and 82%, respectively. There was little difference in accuracy, although not statistically significant, of 78%, 80% and 71%, respectively. In addition, in this study, the sensitivity found was greater than in the study of Bartoletti et al<sup>38</sup>. This is a probable consequence of the selection of patients with typical clinical history of vasovagal syncope. </p>
      <p>More recently, Aerts and Dendale<sup>28</sup> analyzed the accuracy of HUTT without passive phase. The tilt test was carried out with thirty-eight patients and thirty healthy subjects after administration of 400 ug of sublingual nitroglycerin, for a maximum period of 30 minutes. The noted sensitivity was of 82%, the specificity was of 84% and the accuracy of 83%. The authors also reported that, when the results achieved at 15 minutes were analyzed, there was no significant decrease in sensitivity, which suggested that the test could be shorter. Furthermore, compared with previous studies, high sensitivity was found, which the authors attributed to the selection of patients that were strongly suspected of having vasovagal syncope.</p>
      <p>The rate of false negatives in the HUTT during the investigation of vasovagal syncope is still significant - up to 30% when the nitrate is used<sup>14</sup>. Thus, new sensitizing drugs must be tested to reduce this rate. Examinations with false positives are less common, but studies show that, on average, 15% of patients with no history of syncope have a positive result. Undoubtedly, the elucidation of the mechanisms involved and the limits between the physiological response and pathological response will make it easier to interpret the test.</p>
      <p>Other studies are also needed to define the usefulness of HUTT in the prognostic evaluation and treatment planning. On the other hand, the use for monitoring the VVS treatment depends primarily on the confirmation of the treatment effectiveness. Randomized and controlled studies have shown that some medications very used until some time ago and the use of implantable devices are not effective in reducing syncope events<sup>45,46,53</sup>.</p>
      <p>
        <bold>Conclusions</bold>
      </p>
      <p>The head-up tilt test (HUTT) is a helpful tool in the investigation of unexplained syncope. The indiscriminate use, without well-demonstrated methodological criteria, may compromise the credibility and importance of HUTT. </p>
      <p>The test plays an important role in the differential diagnosis and it has been essential to help understand the hemodynamic changes related to dysautonomia. Perhaps, with the evolution of knowledge about the physiopathology and the treatment of these diseases, the results of HUTT can also be used in therapeutic guidance. </p>
      <p>The HUTT methodology has been improved over time. Thus, the proposed protocols should be evaluated considering possible false positives and false negatives, and future studies should be aimed at the development of methods that are more accurate without loss of specificity. </p>
      <p>In conclusion, HUTT is an important noninvasive test in the diagnostic evaluation of unexplained syncope, but it has limitations and sometimes it is not capable of defining the diagnosis. However, these imperfections do not justify abandoning the test. Instead, they justify trying to improve the technique. In clinical practice, HUTT is widely recognized, but the indication must be careful and the protocols shall be in accordance with what was proposed in international standards, so as to enable the correct interpretation of results. </p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of master submitted by Paula Gon&#231;alves Macedo, from <italic>Universidade de Bras&#237;lia</italic>.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
